var title_f19_10_19616="Random effects model";
var content_f19_10_19616=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PC%2F51482&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PC%2F51482&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 640px\">",
"   <div class=\"ttl\">",
"    Random effects model",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 620px; height: 452px; background-image: url(data:image/gif;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    This model assumes that there are multiple treatment effects and that each trial provides an estimate of its own true effect.",
"    <div class=\"footnotes\">",
"     RD: risk difference; OR: odds ratio; RR: relative risk.",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Joseph Lau, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f19_10_19616=[""].join("\n");
var outline_f19_10_19616=null;
var title_f19_10_19617="Nosebleeds (epistaxis)";
var content_f19_10_19617=[" <h1 id=\"patTopicTitle\">",
"  Patient information: Nosebleeds (epistaxis) (Beyond the Basics)",
" </h1>",
" <div id=\"patTopicContributors\">",
"  <div class=\"rcTop\">",
"   <div>",
"   </div>",
"  </div>",
"  <div class=\"rcContent\">",
"   <table>",
"    <tr>",
"     <td>",
"      <a class=\"contributor contributor_credentials patTopicContributorsType\" href=\"UTD.htm?19/10/19617/contributors\">",
"       Authors",
"      </a>",
"      <a class=\"contributor contributor_credentials\" href=\"UTD.htm?19/10/19617/contributors\" id=\"au4645\">",
"       Harrison Alter, MD",
"      </a>",
"      <a class=\"contributor contributor_credentials\" href=\"UTD.htm?19/10/19617/contributors\" id=\"au7431\">",
"       Anna H Messner, MD",
"      </a>",
"     </td>",
"     <td>",
"      <a class=\"contributor contributor_credentials patTopicContributorsType\" href=\"UTD.htm?19/10/19617/contributors\">",
"       Section Editor",
"      </a>",
"      <a class=\"contributor contributor_credentials\" href=\"UTD.htm?19/10/19617/contributors\" id=\"se1963\">",
"       Allan B Wolfson, MD",
"      </a>",
"     </td>",
"     <td>",
"      <a class=\"contributor contributor_credentials patTopicContributorsType\" href=\"UTD.htm?19/10/19617/contributors\">",
"       Deputy Editors",
"      </a>",
"      <a class=\"contributor contributor_credentials\" href=\"UTD.htm?19/10/19617/contributors\" id=\"de97\">",
"       Jonathan Grayzel, MD, FAAEM",
"      </a>",
"      <a class=\"contributor contributor_credentials\" href=\"UTD.htm?19/10/19617/contributors\" id=\"de2799\">",
"       Constanza Villalba, PhD",
"      </a>",
"     </td>",
"    </tr>",
"   </table>",
"  </div>",
"  <div class=\"rcBottom\">",
"   <div>",
"   </div>",
"  </div>",
" </div>",
" <div class=\"patTopicTool\" id=\"patTopicToolTop\">",
"  <a class=\"toolbutton findicon findInPageLink\" href=\"#\" title=\"Find in Topic\">",
"   Find",
"  </a>",
"  <a class=\"toolbutton printicon\" href=\"UTD.htm?19/10/19617?view=print\" title=\"Print This Topic\">",
"   Print",
"  </a>",
"  <script src=\"file://w.sharethis.com/button/sharethis.js#publisher=357881b8-c7e3-4c31-b7d2-242aeb1528e1&amp;type=website&amp;post_services=care2%2Cfacebook%2Ctwitter%2Cmyspace%2Cdigg%2Cdelicious%2Cfaves%2Creddit%2Cxanga%2Cstumbleupon%2Cblinklist%2Csimpy%2Cyigg%2Ctechnorati%2Cmeneame%2Corkut%2Cmixx%2Cfunp%2Cfresqui%2Cmister_wong%2Cfriendster%2Cfriendfeed%2Clinkedin%2Coknotizie%2Cgoogle_bmarks%2Cyahoo_bmarks%2Cfark%2Cnewsvine%2Clivejournal%2Ctypepad%2Cbus_exchange%2Cpropeller%2Cwordpress%2Cblogger%2Cblogmarks%2Cwindows_live%2Cfurl%2Cybuzz%2Cdiigo\" type=\"text/javascript\">",
"  </script>",
" </div>",
" <div id=\"patTopicMiddle\">",
"  <div id=\"topicContent\">",
"   <div id=\"topicText\">",
"    <p class=\"headingAnchor\" id=\"H1\">",
"     <span class=\"h1\">",
"      NOSEBLEED OVERVIEW",
"     </span>",
"    </p>",
"    <p>",
"     Getting a nosebleed or seeing a child get one can be dramatic and scary, but most nosebleeds are nothing to worry about. Nosebleeds (whose technical term is \"epistaxis\") are very common. Almost every person has had at least one in their lifetime. They are usually caused by dry air or nose-picking.",
"    </p>",
"    <p>",
"     If you or your child gets a nosebleed, the important thing is to know how to manage it properly. With the right self-care, most nosebleeds will stop on their own.",
"    </p>",
"    <p>",
"     This topic will outline the circumstances in which a nosebleed warrants immediate medical attention, explain proper self-care for a nosebleed, list the common causes of nosebleeds, and suggest some steps to help prevent recurrent nosebleeds.",
"    </p>",
"    <p class=\"headingAnchor\" id=\"H2\">",
"     <span class=\"h1\">",
"      WHEN TO SEEK HELP",
"     </span>",
"    </p>",
"    <p>",
"     There are two main types of nosebleed, and one can be more serious than the other:",
"    </p>",
"    <p>",
"     <ul class=\"bullet-block\">",
"      <li>",
"       Anterior nosebleeds originate toward the front of the nose and cause blood to flow out through the nostrils. This is the most common type of nosebleed and it is not usually serious.",
"      </li>",
"      <li>",
"       Posterior nosebleeds originate toward the back of the nose, near the throat. Posterior nosebleeds are less common than anterior nosebleeds, but they can be serious and can cause a lot of blood loss. Children do not usually get posterior nosebleeds.",
"      </li>",
"     </ul>",
"    </p>",
"    <p>",
"     You should seek emergency medical care if your nosebleed:",
"    </p>",
"    <p>",
"     <ul class=\"bullet-block\">",
"      <li>",
"       Involves massive bleeding or makes it hard to breathe",
"      </li>",
"      <li>",
"       Causes you to become extremely pale, fatigued, or disoriented",
"      </li>",
"      <li>",
"       Will not stop even after trying the self-care steps outlined below",
"      </li>",
"      <li>",
"       Happens after recent nasal surgery or if you have a known nasal tumor",
"      </li>",
"      <li>",
"       Occurs with other serious symptoms, such as chest pain",
"      </li>",
"      <li>",
"       Occurs after an injury, such as being hit in the face, and you are concerned that you could have other injuries (eg, broken bone)",
"      </li>",
"      <li>",
"       Will not stop bleeding and you take medications that prevent clotting, such as warfarin (Coumadin&reg;), clopidogrel (Plavix&reg;), or daily aspirin",
"      </li>",
"     </ul>",
"    </p>",
"    <p>",
"     If you are having symptoms such as chest pain, lightheadedness, or if bleeding is severe, you should call for emergency medical help. In the United States and Canada, this means calling 911. Do",
"     <strong>",
"      not",
"     </strong>",
"     drive yourself to the hospital and do not ask someone else to drive you. If you drive to the hospital, treatment cannot begin until you arrive in the emergency department.",
"    </p>",
"    <p>",
"     If you are bleeding but do not have other symptoms, have someone else drive you to the hospital.",
"    </p>",
"    <p class=\"headingAnchor\" id=\"H3\">",
"     <span class=\"h1\">",
"      NOSEBLEED SELF-CARE",
"     </span>",
"    </p>",
"    <p>",
"     With the right self-care, most nosebleeds will stop on their own. Here's what you should do if you get one:",
"    </p>",
"    <p>",
"     1. Blow your nose to get rid of some of the clots that have formed inside your nostrils. This may increase the bleeding temporarily, but that's OK.",
"    </p>",
"    <p>",
"     2. Sit or stand while bending forward slightly at the waist. &nbsp;Do not lie down or tilt your head back. This may cause you to swallow blood and can lead to vomiting and other uncomfortable symptoms.",
"    </p>",
"    <p>",
"     3. Grip the soft part of BOTH nostrils at the bottom of your nose (",
"     <a class=\"graphic graphic_picture graphicRef62213 \" href=\"UTD.htm?16/21/16735\">",
"      picture 1",
"     </a>",
"     ). Do not grip the bridge of your nose, as that will not help the bleeding, and do not apply pressure to just one side, even if the bleeding is only on one side.",
"    </p>",
"    <p>",
"     4. Squeeze your nose closed for at least 5 minutes (for children) or 10 to 15 minutes (for adults), and use a clock to time yourself. Do not release the pressure every so often to check whether the bleeding has stopped. Many people hurt their chances of stopping the bleeding by releasing the pressure too soon or too often.",
"    </p>",
"    <p>",
"     5. If you want, you can also apply a cold compress or ice pack to the bridge of your nose. This can help the blood vessels constrict and slow the bleeding. This step is not usually necessary, but many people like to do it.",
"    </p>",
"    <p>",
"     If you follow the steps outlined above, and your nose continues to bleed, repeat all the steps once more. Apply pressure for a total of at least",
"     <strong>",
"      30 minutes",
"     </strong>",
"     . If you continue to bleed even then, seek emergency medical care, either at an emergency room or at an urgent care clinic.",
"    </p>",
"    <p class=\"headingAnchor\" id=\"H4\">",
"     <span class=\"h1\">",
"      NOSEBLEED CAUSES",
"     </span>",
"    </p>",
"    <p>",
"     The inside of the nose has a lot of blood vessels that are close to the surface, so it's easy for them to get irritated or injured. Most nosebleeds are caused by nothing more than the irritation from dry or cold air, or by injury caused by nose-picking.",
"    </p>",
"    <p>",
"     Sometimes people get nosebleeds because they are suffering from allergies or a cold, and their nose has become raw and inflamed. Other times, nosebleeds happen because of an injury to the face caused by a fall, a bike accident, or another type of trauma. Only rarely are nosebleeds caused by serious issues, such as bleeding disorders, blood vessel abnormalities, or cancer.",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H5\">",
"     <span class=\"h2\">",
"      Medications",
"     </span>",
"     &nbsp;&mdash;&nbsp;If you take medications to prevent blood clots, you are more likely to get nosebleeds and to have trouble stopping a nosebleed once it starts.",
"    </p>",
"    <p>",
"     Examples of the medications that can cause these problems include:",
"    </p>",
"    <p>",
"     <ul class=\"bulletCompact-block\">",
"      <li>",
"       Warfarin (Coumadin&reg;)",
"      </li>",
"      <li>",
"       Clopidogrel (Plavix&reg;)",
"      </li>",
"      <li>",
"       Daily aspirin",
"      </li>",
"     </ul>",
"    </p>",
"    <p>",
"     If you take one (or more) of these medications and you get frequent nosebleeds, mention it to your healthcare provider.",
"    </p>",
"    <p>",
"     In addition, nosebleeds can be a side effect of nose sprays used for allergy symptoms (eg, fluticasone [Flonase&reg;], mometasone [Nasonex&reg;], budesonide [Rhinocort&reg;], ciclesonide [Omnaris&reg;], and others). If you use one of these sprays and you develop a nosebleed, talk to your healthcare provider about temporarily stopping the spray for one week. If you get frequent nosebleeds, you may need to completely stop using the spray. An alternate medication, such as an antihistamine pill, may be recommended. (See",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?40/8/41092?source=see_link\">",
"      \"Patient information: Allergic rhinitis (seasonal allergies) (Beyond the Basics)\"",
"     </a>",
"     .)",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H6\">",
"     <span class=\"h2\">",
"      What if I get repeated nosebleeds?",
"     </span>",
"     &nbsp;&mdash;&nbsp;Frequent nosebleeds can be caused by:",
"    </p>",
"    <p>",
"     <ul class=\"bullet-block\">",
"      <li>",
"       Constant exposure to dry air",
"      </li>",
"      <li>",
"       Consistent use of nasal sprays (such as those used to manage allergies or congestion)",
"      </li>",
"      <li>",
"       Recurring colds",
"      </li>",
"      <li>",
"       Snorting drugs into your nose, such as cocaine",
"      </li>",
"     </ul>",
"    </p>",
"    <p>",
"     In some cases, recurring nosebleeds can be a sign of a bleeding disorder. But when bleeding disorders are at play, there are often other clues. For example, people with bleeding disorders tend to bruise easily and may bleed more than expected after minor injuries. (See",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?5/55/6002?source=see_link\">",
"      \"Patient information: von Willebrand disease (Beyond the Basics)\"",
"     </a>",
"     .)",
"    </p>",
"    <p class=\"headingAnchor\" id=\"H7\">",
"     <span class=\"h1\">",
"      NOSEBLEED TREATMENT",
"     </span>",
"    </p>",
"    <p>",
"     If you wind up needing medical care for a nosebleed, your healthcare provider will focus first on making sure you can breathe properly and on getting the bleeding to stop. If you have lost a lot of blood, you may need IV fluids to restore the lost blood.",
"    </p>",
"    <p>",
"     If the bleeding will not stop and the healthcare provider can see the source of the bleeding, he or she may stop the bleeding using a chemical or an electrical device. In severe cases, healthcare providers can pack the nostrils with tampons, gauze, foam, or other materials that can help stop the bleeding. People with serious nosebleeds may need to have a balloon inflated deep within their nose to get the bleeding under control. (See",
"     <a class=\"medical medical_review\" href=\"UTD.htm?1/41/1690?source=see_link\">",
"      \"Approach to the adult with epistaxis\"",
"     </a>",
"     .)",
"    </p>",
"    <p>",
"     A healthcare provider can also check the nose for growths or tumors or for blood vessel abnormalities. A growth or tumor may be more likely if only one nostril bleeds repeatedly or if the blood is tinged with an odorous discharge. Another explanation for one-sided bleeding or odorous discharge is the presence of a foreign body. When examining children with unexplained nosebleeds, healthcare providers often find beads, rubber erasers, and even button batteries rammed deep inside the nose. (See",
"     <a class=\"medical medical_review\" href=\"UTD.htm?17/42/18086?source=see_link\">",
"      \"Evaluation of epistaxis in children\"",
"     </a>",
"     and",
"     <a class=\"medical medical_review\" href=\"UTD.htm?25/58/26536?source=see_link\">",
"      \"Management of epistaxis in children\"",
"     </a>",
"     .)",
"    </p>",
"    <p class=\"headingAnchor\" id=\"H8\">",
"     <span class=\"h1\">",
"      NOSEBLEED PREVENTION",
"     </span>",
"    </p>",
"    <p>",
"     If you get nosebleeds frequently, the following measures may help reduce the chances of getting a nosebleed:",
"    </p>",
"    <p>",
"     <ul class=\"bullet-block\">",
"      <li>",
"       Use a humidifier in your bedroom while sleeping, especially when the air is very dry",
"      </li>",
"      <li>",
"       Keep your nose moist using a saline nasal spray or gel",
"      </li>",
"      <li>",
"       Avoid picking your nose, or &mdash; if you must do it &mdash; clip your fingernails to avoid injury",
"      </li>",
"     </ul>",
"    </p>",
"    <p class=\"headingAnchor\" id=\"H9\">",
"     <span class=\"h1\">",
"      WHERE TO GET MORE INFORMATION",
"     </span>",
"    </p>",
"    <p>",
"     Your healthcare provider is the best source of information for questions and concerns related to your medical problem.",
"    </p>",
"    <p>",
"     This article will be updated as needed on our web site (",
"     <a class=\"external\" href=\"file://www.uptodate.com/patients\">",
"      www.uptodate.com/patients",
"     </a>",
"     ). Related topics for patients, as well as selected articles written for healthcare professionals, are also available. Some of the most relevant are listed below.",
"     <br/>",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H1804469175\">",
"     <span class=\"h2\">",
"      Patient level information",
"     </span>",
"     &nbsp;&mdash;&nbsp;UpToDate offers two types of patient education materials.",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H11167405\">",
"     <span class=\"h3\">",
"      The Basics",
"     </span>",
"     &nbsp;&mdash;&nbsp;The Basics patient education pieces answer the four or five key questions a patient might have about a given condition. These articles are best for patients who want a general overview and who prefer short, easy-to-read materials.",
"    </p>",
"    <p>",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?1/50/1826?source=see_link\">",
"      Patient information: Nosebleeds (The Basics)",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?1/38/1634?source=see_link\">",
"      Patient information: Removing objects stuck up the nose (The Basics)",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?40/4/41026?source=see_link\">",
"      Patient information: Nose fracture (The Basics)",
"     </a>",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H11167439\">",
"     <span class=\"h3\">",
"      Beyond the Basics",
"     </span>",
"     &nbsp;&mdash;&nbsp;Beyond the Basics patient education pieces are longer, more sophisticated, and more detailed. These articles are best for patients who want in-depth information and are comfortable with some medical jargon.",
"    </p>",
"    <p>",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?40/8/41092?source=see_link\">",
"      Patient information: Allergic rhinitis (seasonal allergies) (Beyond the Basics)",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?5/55/6002?source=see_link\">",
"      Patient information: von Willebrand disease (Beyond the Basics)",
"     </a>",
"     <br/>",
"     &nbsp;",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H10\">",
"     <span class=\"h2\">",
"      Professional level information",
"     </span>",
"     &nbsp;&mdash;&nbsp;Professional level articles are designed to keep doctors and other health professionals up-to-date on the latest medical findings. These articles are thorough, long, and complex, and they contain multiple references to the research on which they are based. Professional level articles are best for people who are comfortable with a lot of medical terminology and who want to read the same materials their doctors are reading.",
"    </p>",
"    <p>",
"     <a class=\"medical medical_review\" href=\"UTD.htm?1/41/1690?source=see_link\">",
"      Approach to the adult with epistaxis",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_review\" href=\"UTD.htm?27/16/27912?source=see_link\">",
"      Epidemiology and etiology of epistaxis in children",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_review\" href=\"UTD.htm?17/42/18086?source=see_link\">",
"      Evaluation of epistaxis in children",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_review\" href=\"UTD.htm?25/58/26536?source=see_link\">",
"      Management of epistaxis in children",
"     </a>",
"     <br/>",
"     <br/>",
"     The following organizations also provide reliable health information.",
"    </p>",
"    <p>",
"     <ul class=\"bullet-block\">",
"      <li>",
"       National Library of Medicine",
"      </li>",
"     </ul>",
"    </p>",
"    <p>",
"     &nbsp; &nbsp; &nbsp;(",
"     <a class=\"external\" href=\"file://www.nlm.nih.gov/medlineplus/ency/article/003106.htm\">",
"      www.nlm.nih.gov/medlineplus/ency/article/003106.htm",
"     </a>",
"     , available in Spanish)",
"    </p>",
"    <p>",
"     <ul class=\"bullet-block\">",
"      <li>",
"       KidsHealth",
"      </li>",
"     </ul>",
"    </p>",
"    <p>",
"     &nbsp; &nbsp; &nbsp;(",
"     <a class=\"external\" href=\"file://kidshealth.org/parent/firstaid_safe/emergencies/nose_bleed.html\">",
"      kidshealth.org/parent/firstaid_safe/emergencies/nose_bleed.html",
"     </a>",
"     , available in Spanish)",
"    </p>",
"    <p>",
"     [",
"     <a class=\"abstract\" href=\"UTD.htm?19/10/19617/abstract/1-4\">",
"      1-4",
"     </a>",
"     ]",
"    </p>",
"   </div>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   May 7, 2012.",
"  </div>",
"  <div class=\"patTopicTool\" id=\"patTopicToolBottom\">",
"   <a class=\"toolbutton findicon findInPageLink\" href=\"#\" title=\"Find in Topic\">",
"    Find",
"   </a>",
"   <a class=\"toolbutton printicon\" href=\"UTD.htm?19/10/19617?view=print\" title=\"Print This Topic\">",
"    Print",
"   </a>",
"  </div>",
"  <div id=\"disclaimer\">",
"   The content on the UpToDate website is not intended nor recommended as a substitute",
"for medical advice, diagnosis, or treatment.  Always seek the advice of your own physician or",
"other qualified health care professional regarding any medical questions or conditions.  The",
"use of this website is governed by the",
"   <a href=\"/home/terms-use\" target=\"_blank\">",
"    UpToDate Terms of Use",
"   </a>",
"   &copy;2013 UpToDate, Inc.",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <div id=\"patTopicRefHeader\">",
"    <div id=\"patTopicRefHeaderHeader\">",
"     References",
"    </div>",
"    <div id=\"patTopicRefHeaderTop\">",
"     <a href=\"#top\">",
"      <img alt=\"\" src=\"./../images/top_arrow.myextg\">",
"       Top",
"      </img>",
"     </a>",
"    </div>",
"   </div>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/10/19617/abstract/1\">",
"      Viehweg TL, Roberson JB, Hudson JW. Epistaxis: diagnosis and treatment. J Oral Maxillofac Surg 2006; 64:511.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/10/19617/abstract/2\">",
"      Kucik CJ, Clenney T. Management of epistaxis. Am Fam Physician 2005; 71:305.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/10/19617/abstract/3\">",
"      McGarry G. Nosebleeds in children. Clin Evid 2005; :399.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/10/19617/abstract/4\">",
"      Burton MJ, Dor&eacute;e CJ. Interventions for recurrent idiopathic epistaxis (nosebleeds) in children. Cochrane Database Syst Rev 2004; :CD004461.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
" </div>",
" <!-- patTopicMiddle -->",
"</div>"].join("\n");
var script_f19_10_19617=[""].join("\n");
var outline_f19_10_19617=[" <div class=\"patTopicFancyTop\">",
"  <div class=\"rcTop\">",
"   <div>",
"   </div>",
"  </div>",
"  <div class=\"rcContent\">",
"   <p>",
"    Contents of this article",
"   </p>",
"  </div>",
" </div>",
" <div class=\"patTopicFancySpacer\">",
" </div>",
" <div class=\"patTopicOutline\">",
"  <div class=\"rcbBottom\">",
"   <div class=\"rcbLeft\">",
"    <div class=\"rcbRight\">",
"     <div class=\"rcbBottomLeft\">",
"      <div class=\"rcbBottomRight rcbBottomRightBottomOnly\">",
"       <div id=\"outline\">",
"        <ul>",
"         <li class=\"plainItem\">",
"          <a href=\"#H1\">",
"           NOSEBLEED OVERVIEW",
"          </a>",
"         </li>",
"         <li class=\"plainItem\">",
"          <a href=\"#H2\">",
"           WHEN TO SEEK HELP",
"          </a>",
"         </li>",
"         <li class=\"plainItem\">",
"          <a href=\"#H3\">",
"           NOSEBLEED SELF-CARE",
"          </a>",
"         </li>",
"         <li class=\"plainItem\">",
"          <a href=\"#H4\">",
"           NOSEBLEED CAUSES",
"          </a>",
"         </li>",
"         <li class=\"plainItem\">",
"          <a href=\"#H7\">",
"           NOSEBLEED TREATMENT",
"          </a>",
"         </li>",
"         <li class=\"plainItem\">",
"          <a href=\"#H8\">",
"           NOSEBLEED PREVENTION",
"          </a>",
"         </li>",
"         <li class=\"plainItem\">",
"          <a href=\"#H9\">",
"           WHERE TO GET MORE INFORMATION",
"          </a>",
"         </li>",
"         <li class=\"plainItem\">",
"          <a href=\"#references\">",
"           REFERENCES",
"          </a>",
"         </li>",
"        </ul>",
"       </div>",
"       <h1>",
"        GRAPHICS",
"       </h1>",
"       <div id=\"relatedGraphics\">",
"        <ul>",
"         <li class=\"plainItem\">",
"          PICTURES",
"         </li>",
"         <li class=\"bulletItem\">",
"          <a class=\"graphic graphic_picture\" href=\"UTD.htm?16/21/16735\" title=\"picture 1\">",
"           How to stop a nosebleed PI",
"          </a>",
"         </li>",
"        </ul>",
"       </div>",
"      </div>",
"     </div>",
"    </div>",
"   </div>",
"  </div>",
" </div>"].join("\n");
var title_f19_10_19618="Patient information: Cytomegalovirus (The Basics)";
var content_f19_10_19618=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"1\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div>",
"   &nbsp;",
"  </div>",
"  <div id=\"basicsTopicMinWidth\">",
"   <div id=\"basicsTopicRight\">",
"    <div id=\"placeholder\">",
"     <div class=\"ieSpacer\">",
"     </div>",
"     <div id=\"basics-more\">",
"      <h4>",
"       <img src=\"file://www.uptodate.com/images/basics-more-title.png\"/>",
"      </h4>",
"      <dl>",
"       <dt class=\"basics\">",
"        The Basics",
"       </dt>",
"       <dd>",
"        <a href=\"UTD.htm?32/39/33395\">",
"         Patient information: Avoiding infections in pregnancy (The Basics)",
"        </a>",
"       </dd>",
"       <dd>",
"        <a href=\"UTD.htm?39/40/40578\">",
"         Patient information: Fever in children (The Basics)",
"        </a>",
"       </dd>",
"       <dd>",
"        <a href=\"UTD.htm?40/33/41489\">",
"         Patient information: Mono, the &ldquo;kissing disease&rdquo; (The Basics)",
"        </a>",
"       </dd>",
"       <dd>",
"        <a href=\"UTD.htm?0/57/914\">",
"         Patient information: Sore throat in adults (The Basics)",
"        </a>",
"       </dd>",
"       <dd>",
"        <a href=\"UTD.htm?42/59/43955\">",
"         Patient information: Swollen neck nodes in children (The Basics)",
"        </a>",
"       </dd>",
"       <dt class=\"beyondthebasics\">",
"        Beyond the Basics",
"       </dt>",
"       <dd>",
"        <a href=\"UTD.htm?0/11/176\">",
"         Patient information: Infectious mononucleosis (mono) in adults and adolescents (Beyond the Basics)",
"        </a>",
"       </dd>",
"      </dl>",
"      <div id=\"tooltipper\">",
"      </div>",
"     </div>",
"    </div>",
"   </div>",
"   <div id=\"basicsTopicLeft\">",
"    <div id=\"topicTitle\">",
"     Patient information: Cytomegalovirus (The Basics)",
"    </div>",
"    <span class=\"view\">",
"     View in",
"     <a class=\"lang\" href=\"./es-419/cytomegalovirus-the-basics?source=topic_page\">",
"      Spanish",
"     </a>",
"    </span>",
"    <a class=\"contributor contributor_credentials\" href=\"./authors-and-editors/patient-information\">",
"     Written by the doctors and editors at UpToDate",
"    </a>",
"    <div id=\"topicText\">",
"     <p class=\"headingAnchor\" id=\"H8432697\">",
"      <span class=\"h1\">",
"       What is cytomegalovirus (CMV)?",
"      </span>",
"      &nbsp;&mdash;&nbsp;Cytomegalovirus is a virus that can cause a fever, tiredness, and other symptoms. Doctors also call it &ldquo;CMV.&rdquo;",
"     </p>",
"     <p>",
"      CMV is very common. Many people have the virus without knowing it. Some people don&rsquo;t get sick when they have it, but others do.",
"     </p>",
"     <p>",
"      CMV can cause serious illness in people with conditions that weaken the body&rsquo;s infection-fighting system (called the &ldquo;immune system&rdquo;). These conditions include:",
"     </p>",
"     <p>",
"      <ul class=\"bullet-block\">",
"       <li>",
"        An organ transplant, such as a new kidney or lung",
"       </li>",
"       <li>",
"        A bone marrow transplant",
"       </li>",
"       <li>",
"        HIV &ndash; This is the virus that causes AIDS.",
"       </li>",
"       <li>",
"        Being in the hospital for a long time, especially in the intensive care unit (also called the &ldquo;ICU&rdquo;).",
"       </li>",
"      </ul>",
"     </p>",
"     <p>",
"      CMV can be very serious for people with these conditions. It can even be life-threatening. &nbsp;",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H8432712\">",
"      <span class=\"h1\">",
"       What are the symptoms of CMV?",
"      </span>",
"      &nbsp;&mdash;&nbsp;Many people who have the virus do not have symptoms. If symptoms happen, they are usually mild in people with healthy immune systems. People with weak immune systems can have more severe symptoms.",
"     </p>",
"     <p>",
"      The most common symptom of CMV is an illness called &ldquo;mononucleosis&rdquo; or &ldquo;mono.&rdquo; But CMV is not always the cause of mono. A doctor or nurse can tell if CMV is the cause.",
"     </p>",
"     <p>",
"      Common symptoms of mono from CMV include:",
"     </p>",
"     <p>",
"      <ul class=\"bulletCompact-block\">",
"       <li>",
"        Fever",
"       </li>",
"       <li>",
"        Tiredness",
"       </li>",
"       <li>",
"        Body aches",
"       </li>",
"       <li>",
"        Sore throat",
"       </li>",
"       <li>",
"        Swollen glands in the neck &ndash; This is more common in children than adults.",
"       </li>",
"      </ul>",
"     </p>",
"     <p>",
"      Less common CMV symptoms can happen in specific parts of the body. These symptoms are more likely to happen in people with weak immune systems. They can include:",
"     </p>",
"     <p>",
"      <ul class=\"bulletCompact-block\">",
"       <li>",
"        Digestive system problems, such as bloody diarrhea and belly pain",
"       </li>",
"       <li>",
"        Lung problems, such as trouble breathing and dry cough",
"       </li>",
"       <li>",
"        Problems with the liver, eyes, nervous system, or heart",
"       </li>",
"      </ul>",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H8432727\">",
"      <span class=\"h1\">",
"       Will I need tests?",
"      </span>",
"      &nbsp;&mdash;&nbsp;Yes. There are several tests, but you probably will not need all of them. Tests can include:",
"     </p>",
"     <p>",
"      <ul class=\"bulletCompact-block\">",
"       <li>",
"        Blood tests",
"       </li>",
"       <li>",
"        Urine tests",
"       </li>",
"       <li>",
"        Tests on a sample of fluid from your lungs, throat, or other part of the body",
"       </li>",
"       <li>",
"        Tests on a sample of tissue from an affected body part",
"       </li>",
"      </ul>",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H8432744\">",
"      <span class=\"h1\">",
"       How is CMV treated?",
"      </span>",
"      &nbsp;&mdash;&nbsp;People with healthy immune systems who get sick with CMV do not usually need treatment. They usually feel better in a few days or weeks. Medicines like",
"      <a class=\"drug drug_patient\" href=\"UTD.htm?19/35/20021?source=see_link\">",
"       acetaminophen",
"      </a>",
"      &nbsp;(sample brand name: Tylenol&reg;) or",
"      <a class=\"drug drug_patient\" href=\"UTD.htm?14/17/14614?source=see_link\">",
"       ibuprofen",
"      </a>",
"      &nbsp;(sample brand names: Advil&reg;, Motrin&reg;) can relieve mild symptoms of CMV. If you take these medicines, be sure to follow the directions on the label.",
"     </p>",
"     <p>",
"      Doctors can treat severe CMV symptoms with medicines, such as",
"      <a class=\"drug drug_patient\" href=\"UTD.htm?37/48/38656?source=see_link\">",
"       ganciclovir",
"      </a>",
"      (brand name: Cytovene&reg;-IV). Ganciclovir is given through a thin tube called an &ldquo;IV.&rdquo; The tube goes into a vein. Ganciclovir is usually given to people with CMV who have weak immune systems.",
"     </p>",
"     <p>",
"      When a person gets an organ transplant, doctors might give a pill, such as",
"      <a class=\"drug drug_patient\" href=\"UTD.htm?19/29/19925?source=see_link\">",
"       valganciclovir",
"      </a>",
"      (brand name: Valcyte&reg;), to help prevent CMV. Some people with severe CMV symptoms get this medicine instead of",
"      <a class=\"drug drug_patient\" href=\"UTD.htm?37/48/38656?source=see_link\">",
"       ganciclovir",
"      </a>",
"      , even if they have not had an organ transplant. &nbsp;",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H8432759\">",
"      <span class=\"h1\">",
"       What if I am pregnant?",
"      </span>",
"      &nbsp;&mdash;&nbsp;Tell your doctor or nurse if you have a fever, sore throat, and body aches. He or she might do a blood test to check for CMV. You might also have the test if you have a condition that weakens your immune system. This is because you can give the CMV infection to your unborn baby.",
"     </p>",
"     <p>",
"      CMV can cause serious health problems in some newborn babies, so it is important to know if you have it. That way, doctors can look for problems in the baby and treat them if they happen. Problems can include:",
"     </p>",
"     <p>",
"      <ul class=\"bulletCompact-block\">",
"       <li>",
"        Hearing loss",
"       </li>",
"       <li>",
"        Seizures",
"       </li>",
"       <li>",
"        Eye problems",
"       </li>",
"       <li>",
"        Problems with learning and growing",
"       </li>",
"      </ul>",
"     </p>",
"     <p>",
"      Most people don&rsquo;t know if they have CMV or not. But if you are pregnant or trying to get pregnant, it&rsquo;s a good idea to do things that reduce your chances of getting it, just in case. You can:",
"     </p>",
"     <p>",
"      <ul class=\"bullet-block\">",
"       <li>",
"        Avoid kissing toddlers and children on the mouth.",
"       </li>",
"       <li>",
"        Avoid sharing eating or drinking utensils, drinks, or food with toddlers or young children.",
"       </li>",
"       <li>",
"        Wash your hands well after changing diapers or wiping a child&rsquo;s nose or face.",
"       </li>",
"       <li>",
"        Avoid having sex if your partner is sick with a CMV infection. CMV can be spread by sex.",
"       </li>",
"      </ul>",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H8432774\">",
"      <span class=\"h1\">",
"       More on this topic",
"      </span>",
"     </p>",
"     <p>",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?32/39/33395?source=see_link\">",
"       Patient information: Avoiding infections in pregnancy (The Basics)",
"      </a>",
"      <br/>",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?39/40/40578?source=see_link\">",
"       Patient information: Fever in children (The Basics)",
"      </a>",
"      <br/>",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?40/33/41489?source=see_link\">",
"       Patient information: Mono, the &ldquo;kissing disease&rdquo; (The Basics)",
"      </a>",
"      <br/>",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?42/59/43955?source=see_link\">",
"       Patient information: Swollen neck nodes in children (The Basics)",
"      </a>",
"     </p>",
"     <p>",
"      <a class=\"medical medical_patient\" href=\"UTD.htm?0/11/176?source=see_link\">",
"       Patient information: Infectious mononucleosis (mono) in adults and adolescents (Beyond the Basics)",
"      </a>",
"      <br/>",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?0/57/914?source=see_link\">",
"       Patient information: Sore throat in adults (The Basics)",
"      </a>",
"     </p>",
"    </div>",
"    <div id=\"reviewProcess\">",
"     <span>",
"      All topics are updated as new evidence becomes available and our",
"      <a class=\"policy policy_editorialpolicy\" href=\"/home/editorial-policy\">",
"       peer review process",
"      </a>",
"      is complete.",
"     </span>",
"    </div>",
"    <div id=\"topicRetrievedDate\">",
"     <span class=\"emphasis\">",
"      This topic retrieved from UpToDate on:",
"     </span>",
"     Apr 20, 2013.",
"    </div>",
"    <div class=\"patTopicTool\" id=\"patTopicToolBottom\">",
"     <a class=\"toolbutton findicon findInPageLink\" href=\"#\" title=\"Find in Topic\">",
"      Find",
"     </a>",
"     <a class=\"toolbutton printicon\" href=\"UTD.htm?19/10/19618?view=print\" title=\"Print This Topic\">",
"      Print",
"     </a>",
"     <a class=\"toolbutton emailicon etacLink\" href=\"#\" title=\"Email This Topic\">",
"      Email",
"     </a>",
"    </div>",
"    <div id=\"disclaimer\">",
"     The content on the UpToDate website is not intended nor recommended as a substitute for medical advice, diagnosis, or treatment.  Always seek the advice of your own physician or other qualified health care professional regarding any medical questions or conditions.",
"The use of UpToDate content is governed by the",
"     <a class=\"legal legal_termsofuse\" href=\"/home/terms-use\" target=\"_blank\">",
"      UpToDate Terms of Use",
"     </a>",
"     . &copy;2013 UpToDate, Inc. All rights reserved.",
"    </div>",
"    <div id=\"topicVersionRevision\">",
"     Topic 83958 Version 1.0",
"    </div>",
"   </div>",
"   <!--  basicsTopicLeft -->",
"  </div>",
"  <!-- basicsTopicMinWidth -->",
" </div>",
" <!-- topicContent -->",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1004-197.136.42.3-3C9D172F08-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f19_10_19618=[""].join("\n");
var outline_f19_10_19618=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H8432697\">",
"      What is cytomegalovirus (CMV)?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H8432712\">",
"      What are the symptoms of CMV?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H8432727\">",
"      Will I need tests?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H8432744\">",
"      How is CMV treated?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H8432759\">",
"      What if I am pregnant?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H8432774\">",
"      More on this topic",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?32/39/33395?source=related_link\">",
"      Patient information: Avoiding infections in pregnancy (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?39/40/40578?source=related_link\">",
"      Patient information: Fever in children (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?0/11/176?source=related_link\">",
"      Patient information: Infectious mononucleosis (mono) in adults and adolescents (Beyond the Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?40/33/41489?source=related_link\">",
"      Patient information: Mono, the &ldquo;kissing disease&rdquo; (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?0/57/914?source=related_link\">",
"      Patient information: Sore throat in adults (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?42/59/43955?source=related_link\">",
"      Patient information: Swollen neck nodes in children (The Basics)",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f19_10_19619="Multiple vitamins: Drug information";
var content_f19_10_19619=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"3\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"drugTitle\">",
"   Multiple vitamins: Drug information",
"  </div>",
"  <div id=\"lexiTitleImg\">",
"   <img height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"  </div>",
"  <div class=\"clear\">",
"  </div>",
"  <div id=\"drugCopy\">",
"   Copyright 1978-2013 Lexicomp, Inc. All rights reserved.",
"  </div>",
"  <div id=\"topicText\">",
"   (For additional information",
"   <a class=\"drug drug_patient\" href=\"UTD.htm?23/30/24036?source=see_link\">",
"    see \"Multiple vitamins: Patient drug information\"",
"   </a>",
"   )",
"   <br/>",
"   For abbreviations and symbols that may be used in Lexicomp (",
"   <a class=\"graphic graphic_table\" href=\"UTD.htm?23/39/24183\">",
"    show table",
"   </a>",
"   )",
"   <div class=\"block black-box-warn drugH1Div\" id=\"F5708849\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     ALERT: U.S. Boxed Warning",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     The FDA-approved labeling includes a boxed warning. See Warnings/Precautions section for a concise summary of this information.  For verbatim wording of the boxed warning, consult the product labeling or",
"     <a href=\"file://www.fda.gov\" target=\"_blank\">",
"      www.fda.gov",
"     </a>",
"     .",
"    </p>",
"   </div>",
"   <div class=\"list ubnlist drugH1Div drugBrandNames\" id=\"F234725\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: U.S.",
"    </span>",
"    <ul>",
"     <li>",
"      Androvite&reg; [OTC];",
"     </li>",
"     <li>",
"      CalciFolic-D&trade;;",
"     </li>",
"     <li>",
"      Centamin [OTC];",
"     </li>",
"     <li>",
"      Centrum Cardio&reg; [OTC];",
"     </li>",
"     <li>",
"      Centrum Performance&reg; [OTC];",
"     </li>",
"     <li>",
"      Centrum&reg; Silver&reg; Ultra Men's [OTC];",
"     </li>",
"     <li>",
"      Centrum&reg; Silver&reg; Ultra Women's [OTC];",
"     </li>",
"     <li>",
"      Centrum&reg; Silver&reg; [OTC];",
"     </li>",
"     <li>",
"      Centrum&reg; Ultra Men's [OTC];",
"     </li>",
"     <li>",
"      Centrum&reg; Ultra Women's [OTC];",
"     </li>",
"     <li>",
"      Centrum&reg; [OTC];",
"     </li>",
"     <li>",
"      Diatx&reg;Zn;",
"     </li>",
"     <li>",
"      Drinkables&reg; Fruits and Vegetables [OTC];",
"     </li>",
"     <li>",
"      Drinkables&reg; MultiVitamins [OTC];",
"     </li>",
"     <li>",
"      Encora&reg;;",
"     </li>",
"     <li>",
"      Foltrin&reg;;",
"     </li>",
"     <li>",
"      Freedavite [OTC];",
"     </li>",
"     <li>",
"      Geri-Freeda [OTC];",
"     </li>",
"     <li>",
"      Geriation [OTC];",
"     </li>",
"     <li>",
"      Geritol Complete&reg; [OTC];",
"     </li>",
"     <li>",
"      Geritol Extend&reg; [OTC];",
"     </li>",
"     <li>",
"      Geritol&reg; Tonic [OTC];",
"     </li>",
"     <li>",
"      Glutofac&reg;-MX;",
"     </li>",
"     <li>",
"      Gynovite&reg; Plus [OTC];",
"     </li>",
"     <li>",
"      Hemocyte Plus&reg;;",
"     </li>",
"     <li>",
"      Hi-Kovite [OTC];",
"     </li>",
"     <li>",
"      Iberet&reg;-500 [OTC] [DSC];",
"     </li>",
"     <li>",
"      Monocaps [OTC];",
"     </li>",
"     <li>",
"      Myadec&reg; [OTC];",
"     </li>",
"     <li>",
"      Nutrimin-Plus [OTC];",
"     </li>",
"     <li>",
"      Ocuvite&reg; Adult 50+ [OTC];",
"     </li>",
"     <li>",
"      Ocuvite&reg; Extra&reg; [OTC];",
"     </li>",
"     <li>",
"      Ocuvite&reg; Lutein [OTC];",
"     </li>",
"     <li>",
"      Ocuvite&reg; [OTC];",
"     </li>",
"     <li>",
"      One A Day&reg; Cholesterol Plus [OTC];",
"     </li>",
"     <li>",
"      One A Day&reg; Energy [OTC];",
"     </li>",
"     <li>",
"      One A Day&reg; Essential [OTC];",
"     </li>",
"     <li>",
"      One A Day&reg; Maximum [OTC];",
"     </li>",
"     <li>",
"      One A Day&reg; Men's 50+ Advantage [OTC];",
"     </li>",
"     <li>",
"      One A Day&reg; Men's Health Formula [OTC];",
"     </li>",
"     <li>",
"      One A Day&reg; Teen Advantage for Her [OTC];",
"     </li>",
"     <li>",
"      One A Day&reg; Teen Advantage for Him [OTC];",
"     </li>",
"     <li>",
"      One A Day&reg; Weight Smart&reg; Advanced [OTC];",
"     </li>",
"     <li>",
"      One A Day&reg; Women's 50+ Advantage  [OTC];",
"     </li>",
"     <li>",
"      One A Day&reg; Women&rsquo;s Active Mind &amp; Body [OTC];",
"     </li>",
"     <li>",
"      One A Day&reg; Women&rsquo;s [OTC];",
"     </li>",
"     <li>",
"      Optivite&reg; P.M.T. [OTC];",
"     </li>",
"     <li>",
"      PreserVision&reg; AREDS [OTC];",
"     </li>",
"     <li>",
"      PreserVision&reg; Lutein [OTC];",
"     </li>",
"     <li>",
"      Quintabs [OTC];",
"     </li>",
"     <li>",
"      Quintabs-M Iron-Free [OTC];",
"     </li>",
"     <li>",
"      Quintabs-M [OTC];",
"     </li>",
"     <li>",
"      Renax&reg;;",
"     </li>",
"     <li>",
"      Renax&reg; 5.5;",
"     </li>",
"     <li>",
"      Replace Without Iron [OTC];",
"     </li>",
"     <li>",
"      Replace [OTC];",
"     </li>",
"     <li>",
"      Repliva 21/7&reg;;",
"     </li>",
"     <li>",
"      SourceCF&reg;;",
"     </li>",
"     <li>",
"      Strovite&reg;;",
"     </li>",
"     <li>",
"      Strovite&reg; Advance;",
"     </li>",
"     <li>",
"      Strovite&reg; Forte;",
"     </li>",
"     <li>",
"      Strovite&reg; Plus;",
"     </li>",
"     <li>",
"      T-Vites [OTC];",
"     </li>",
"     <li>",
"      Ultra Freeda A-Free [OTC];",
"     </li>",
"     <li>",
"      Ultra Freeda Iron-Free [OTC];",
"     </li>",
"     <li>",
"      Ultra Freeda With Iron [OTC];",
"     </li>",
"     <li>",
"      Viactiv&reg; Calcium Flavor Glides&trade; [OTC];",
"     </li>",
"     <li>",
"      Viactiv&reg; Flavor Glides [OTC];",
"     </li>",
"     <li>",
"      Viactiv&reg; for Teens [OTC];",
"     </li>",
"     <li>",
"      Viactiv&reg; With Calcium [OTC];",
"     </li>",
"     <li>",
"      Viactiv&reg; [OTC];",
"     </li>",
"     <li>",
"      Vitafol&reg;;",
"     </li>",
"     <li>",
"      Xtramins [OTC];",
"     </li>",
"     <li>",
"      Yelets [OTC]",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ex_sect_xr thclist drugH1Div drugBrandNames\" id=\"F234735\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pharmacologic Category",
"    </span>",
"    <ul>",
"     <li>",
"      Vitamin",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"block doa drugH1Div\" id=\"F234726\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Adult",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     <b>",
"      Dietary supplement:",
"     </b>",
"     Oral: Daily dose of adult preparations varies by product. Generally, 1 tablet or capsule or 5-15 mL of liquid per day. Consult package labeling. Prescription doses may be higher for burn or cystic fibrosis patients.",
"    </p>",
"   </div>",
"   <div class=\"block doe drugH1Div\" id=\"F234727\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Geriatric",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Refer to adult dosing.",
"    </p>",
"   </div>",
"   <div class=\"block foc drugH1Div\" id=\"F234713\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosage Forms: U.S.",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Excipient information presented when available (limited, particularly for generics); consult specific product labeling.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Content varies depending on product used. For more detailed information on ingredients in these and other multivitamins, please refer to",
"     <b>",
"      Multivitamin Product",
"     </b>",
"     comparison table.",
"    </p>",
"   </div>",
"   <div class=\"block geq drugH1Div\" id=\"F234702\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Generic Equivalent Available: U.S.",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Yes",
"    </p>",
"   </div>",
"   <div class=\"block adm drugH1Div\" id=\"F234717\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Administration",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     May administer with food to decrease stomach upset.",
"    </p>",
"   </div>",
"   <div class=\"block use drugH1Div\" id=\"F234716\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Use",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Prevention/treatment of vitamin and mineral deficiencies; labeled for OTC use as a dietary supplement",
"    </p>",
"   </div>",
"   <div class=\"block mst drugH1Div\" id=\"F234741\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Medication Safety Issues",
"    </span>",
"    <div class=\"collapsible\">",
"     <span class=\"collapsible-title\">",
"      Sound-alike/look-alike issues:",
"     </span>",
"     <div class=\"collapsible-wrap\">",
"      <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"       Theragran&reg; may be confused with Phenergan&reg;",
"      </p>",
"      <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"       Viactiv&reg; may be confused with Vibativ&trade;",
"      </p>",
"     </div>",
"    </div>",
"   </div>",
"   <div class=\"block ars drugH1Div\" id=\"F234733\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Adverse Reactions Significant",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     See individual vitamin monographs.",
"    </p>",
"   </div>",
"   <div class=\"block coi drugH1Div\" id=\"F234719\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Contraindications",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Hypersensitivity to any component of the formulation; pre-existing hypervitaminosis",
"    </p>",
"   </div>",
"   <div class=\"block war drugH1Div\" id=\"F234705\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Warnings/Precautions",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      <i>",
"       Concerns related to adverse effects:",
"      </i>",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Iron toxicity:",
"     <b>",
"      [U.S. Boxed Warning]: Severe iron toxicity may occur in overdose, particularly when ingested by children; iron is a leading cause of fatal poisoning in children; store out of children's reach and in child-resistant containers.",
"     </b>",
"     Adult preparations may contain amounts of iron which should not be used in children.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      <i>",
"       Disease-related concerns:",
"      </i>",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Hepatic impairment: Use with caution in patients with severe hepatic impairment.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Renal impairment: Use with caution in patients with severe renal impairment.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      <i>",
"       Dosage form specific issues:",
"      </i>",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Ethanol: Adult preparations may contain amounts of ethanol which should not be used in children.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      <i>",
"       Other warnings/precautions:",
"      </i>",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; RDA values: Are not requirements, but are recommended daily intakes of certain essential nutrients.",
"    </p>",
"   </div>",
"   <div class=\"block foi drugH1Div\" id=\"F234723\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Ethanol/Nutrition/Herb Interactions",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Food: Iron absorption is inhibited by eggs and milk.",
"    </p>",
"   </div>",
"   <div class=\"block pri drugH1Div\" id=\"F14191341\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pregnancy Implications",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Refer to individual vitamin monographs for requirements during pregnancy.",
"    </p>",
"   </div>",
"   <div class=\"block brc drugH1Div\" id=\"F14191342\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Breast-Feeding Considerations",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Refer to individual vitamin monographs for requirements while breast-feeding.",
"    </p>",
"   </div>",
"   <div class=\"block dic drugH1Div\" id=\"F234721\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dietary Considerations",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     May be taken with food to decrease stomach upset.",
"    </p>",
"   </div>",
"   <div class=\"block fee drugH1Div\" id=\"F16324108\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pricing: U.S. (Medi-Span&reg;)",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Capsules",
"     </b>",
"     (Nephrocaps Oral)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     1 mg (30): $23.71",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Chewable",
"     </b>",
"     (Viactiv Oral)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     500-500-40 mg-unit-mcg (60): $6.91",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Tablets",
"     </b>",
"     (Vinacal Oral)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     27-1 mg (90): $96.92",
"    </p>",
"   </div>",
"   <div class=\"block rer drugH1Div\" id=\"F234714\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Reference Range",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Recommended daily allowances are published by Food and Nutrition Board, National Research Council - National Academy of Sciences and are revised periodically. RDA quantities apply only to healthy persons and are not intended to cover therapeutic nutrition requirements in disease or other abnormal states (ie, metabolic disorders, weight reduction, chronic disease, drug therapy).",
"    </p>",
"   </div>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 10318 Version 29.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1103-201.211.0.116-039B397C7E-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f19_10_19619=[""].join("\n");
var outline_f19_10_19619=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F5708849\">",
"      ALERT: U.S. Boxed Warning",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F234725\">",
"      Brand Names: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F234735\">",
"      Pharmacologic Category",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F234726\">",
"      Dosing: Adult",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F234727\">",
"      Dosing: Geriatric",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F234713\">",
"      Dosage Forms: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F234702\">",
"      Generic Equivalent Available: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F234717\">",
"      Administration",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F234716\">",
"      Use",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F234741\">",
"      Medication Safety Issues",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F234733\">",
"      Adverse Reactions Significant",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F234719\">",
"      Contraindications",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F234705\">",
"      Warnings/Precautions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F234723\">",
"      Ethanol/Nutrition/Herb Interactions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F14191341\">",
"      Pregnancy Implications",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F14191342\">",
"      Breast-Feeding Considerations",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F234721\">",
"      Dietary Considerations",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F16324108\">",
"      Pricing: U.S. (Medi-Span&reg;)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F234714\">",
"      Reference Range",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"DRUG_GEN/10318\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"DRUG_GEN/10318|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?23/39/24183\" title=\"Lexicomp clinical abbreviations\">",
"      Lexicomp clinical abbreviations",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_patient\" href=\"UTD.htm?23/30/24036?source=related_link\">",
"      Multiple vitamins: Patient drug information",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f19_10_19620="Annular lichen planus";
var content_f19_10_19620=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=DERM%2F68197&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=DERM%2F68197&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 524px\">",
"   <div class=\"ttl\">",
"    Annular lichen planus",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 504px; height: 378px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    A violaceous annular plaque is present.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: www.visualdx.com. Copyright Logical Images, Inc.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f19_10_19620=[""].join("\n");
var outline_f19_10_19620=null;
var title_f19_10_19621="Extrafollicular penetration in pseudofolliculitis barbae";
var content_f19_10_19621=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=DERM%2F87582%7EDERM%2F87583&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=DERM%2F87582%7EDERM%2F87583&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 523px\">",
"   <div class=\"ttl\">",
"    Extrafollicular penetration in pseudofolliculitis barbae",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 503px; height: 287px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Reentry of the hair&nbsp;into the skin occurs after the hair has exited the follicle.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 523px\">",
"   <div class=\"ttl\">",
"    Transfollicular penetration in pseudofolliculitis barbae",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 503px; height: 263px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Entry of the hair into the interfollicular skin occurs prior to exiting of the hair from the follicle.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f19_10_19621=[""].join("\n");
var outline_f19_10_19621=null;
var title_f19_10_19622="Percutaneous suprapubic catheter placement";
var content_f19_10_19622=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=SURG%2F72720&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=SURG%2F72720&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 544px\">",
"   <div class=\"ttl\">",
"    Percutaneous suprapubic catheter placement",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 524px; height: 712px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Percutaneous suprapubic catheters are placed using sterile technique with local anesthesia, and sedation if needed. Ultrasound is used to verify full bladder distension prior to the procedure. The lower abdominal skin is prepared and lidocaine is injected in the midline, 2 centimeters above the symphysis pubis. The catheter is placed through a small skin incision into the bladder either with a direct puncture or Seldinger technique. For the direct puncture technique, a mushroom catheter is straightened with a stylet and advanced into the bladder. Once the catheter is confirmed within the bladder, the stylet is removed. For the Seldinger technique, a needle is inserted until urine is aspirated. A guidewire is placed through the needle into the bladder and the needle is removed. A dilator is advanced over the wire enlarging the tract. The dilator is then replaced with a sheath, the guidewire removed, and the catheter placed through the sheath which is then peeled away. The catheter balloon is inflated and the catheter gently withdrawn until slight tension is felt. The catheter is then connected to the catheter drainage system and secured to the patient.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f19_10_19622=[""].join("\n");
var outline_f19_10_19622=null;
var title_f19_10_19623="MRI MTS T2";
var content_f19_10_19623=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=NEURO%2F77659%7ENEURO%2F69972&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=NEURO%2F77659%7ENEURO%2F69972&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    T2-weighted MR image showing mild left sided mesial temporal sclerosis in a round hippocampal variant",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 360px; height: 378px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Note the decreased volume and abnormal increased T2 signal of the hippocampus (arrow) and atrophy of the left temporal lobe, including the white matter.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    MRI MTS FLAIR",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 360px; height: 377px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    FLAIR sequence of the same patient; because FLAIR (fluid-attenuated inversion recovery imaging) nulls CSF signal, abnormal signal intensity in the hippocampus (arrow) is relatively more apparent.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f19_10_19623=[""].join("\n");
var outline_f19_10_19623=null;
var title_f19_10_19624="Aspirin: Pediatric drug information";
var content_f19_10_19624=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"3\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"drugTitle\">",
"   Aspirin: Pediatric drug information",
"  </div>",
"  <div id=\"lexiTitleImg\">",
"   <img height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"  </div>",
"  <div class=\"clear\">",
"  </div>",
"  <div id=\"drugCopy\">",
"   Copyright 1978-2013 Lexicomp, Inc. All rights reserved.",
"  </div>",
"  <div id=\"topicText\">",
"   (For additional information",
"   <a class=\"drug drug_general\" href=\"UTD.htm?24/7/24698?source=see_link\">",
"    see \"Aspirin: Drug information\"",
"   </a>",
"   and",
"   <a class=\"drug drug_patient\" href=\"UTD.htm?6/12/6342?source=see_link\">",
"    see \"Aspirin: Patient drug information\"",
"   </a>",
"   )",
"   <br/>",
"   For abbreviations and symbols that may be used in Lexicomp (",
"   <a class=\"graphic graphic_table\" href=\"UTD.htm?23/39/24183\">",
"    show table",
"   </a>",
"   )",
"   <div class=\"list ubnlist drugH1Div drugBrandNames\" id=\"F137093\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: U.S.",
"    </span>",
"    <ul>",
"     <li>",
"      Ascriptin&reg; Maximum Strength [OTC];",
"     </li>",
"     <li>",
"      Ascriptin&reg; Regular Strength [OTC];",
"     </li>",
"     <li>",
"      Aspercin [OTC];",
"     </li>",
"     <li>",
"      Aspergum&reg; [OTC];",
"     </li>",
"     <li>",
"      Aspir-low [OTC];",
"     </li>",
"     <li>",
"      Aspirtab [OTC];",
"     </li>",
"     <li>",
"      Bayer&reg; Aspirin Extra Strength [OTC];",
"     </li>",
"     <li>",
"      Bayer&reg; Aspirin Regimen Adult Low Strength [OTC];",
"     </li>",
"     <li>",
"      Bayer&reg; Aspirin Regimen Children's [OTC];",
"     </li>",
"     <li>",
"      Bayer&reg; Aspirin Regimen Regular Strength [OTC];",
"     </li>",
"     <li>",
"      Bayer&reg; Genuine Aspirin [OTC];",
"     </li>",
"     <li>",
"      Bayer&reg; Plus Extra Strength [OTC];",
"     </li>",
"     <li>",
"      Bayer&reg; Women's Low Dose Aspirin [OTC];",
"     </li>",
"     <li>",
"      Buffasal [OTC];",
"     </li>",
"     <li>",
"      Bufferin&reg; Extra Strength [OTC];",
"     </li>",
"     <li>",
"      Bufferin&reg; [OTC];",
"     </li>",
"     <li>",
"      Buffinol [OTC];",
"     </li>",
"     <li>",
"      Ecotrin&reg; Arthritis Strength [OTC];",
"     </li>",
"     <li>",
"      Ecotrin&reg; Low Strength [OTC];",
"     </li>",
"     <li>",
"      Ecotrin&reg; [OTC];",
"     </li>",
"     <li>",
"      Halfprin&reg; [OTC];",
"     </li>",
"     <li>",
"      St Joseph&reg; Adult Aspirin [OTC];",
"     </li>",
"     <li>",
"      Tri-Buffered Aspirin [OTC]",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"list cbnlist drugH1Div drugBrandNames\" id=\"F137094\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: Canada",
"    </span>",
"    <ul>",
"     <li>",
"      Asaphen;",
"     </li>",
"     <li>",
"      Asaphen E.C.;",
"     </li>",
"     <li>",
"      Entrophen&reg;;",
"     </li>",
"     <li>",
"      Novasen;",
"     </li>",
"     <li>",
"      Praxis ASA EC 81 Mg Daily Dose",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"list_set htclist drugH1Div drugBrandNames\" id=\"F1051174\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Therapeutic Category",
"    </span>",
"    <ul>",
"     <li>",
"      <span class=\"list-set-name\">",
"       Analgesic, Non-narcotic",
"      </span>",
"     </li>",
"     <li>",
"      <span class=\"list-set-name\">",
"       Anti-inflammatory Agent",
"      </span>",
"     </li>",
"     <li>",
"      <span class=\"list-set-name\">",
"       Antiplatelet Agent",
"      </span>",
"     </li>",
"     <li>",
"      <span class=\"list-set-name\">",
"       Antipyretic",
"      </span>",
"     </li>",
"     <li>",
"      <span class=\"list-set-name\">",
"       Nonsteroidal Anti-inflammatory Drug (NSAID), Oral",
"      </span>",
"     </li>",
"     <li>",
"      <span class=\"list-set-name\">",
"       Salicylate",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"block don drugH1Div\" id=\"F12669217\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Neonatal",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Full-term neonate: Antiplatelet effects: Postoperative congenital heart repair or recurrent arterial ischemic stroke: Oral: Adequate neonatal studies have not been performed; neonatal dosage is derived from clinical experience and is not well established; suggested doses: 1-5 mg/kg/day as a single daily dose (Monagle, 2008). Doses are typically rounded to a convenient amount (eg,",
"     <sup>",
"      1",
"     </sup>",
"     /",
"     <sub>",
"      4",
"     </sub>",
"     of 81 mg tablet)",
"    </p>",
"   </div>",
"   <div class=\"block dos drugH1Div\" id=\"F1051166\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Usual",
"    </span>",
"    <p>",
"     (For additional information",
"     <a class=\"drug drug_general\" href=\"UTD.htm?24/7/24698?source=see_link\">",
"      see \"Aspirin: Drug information\"",
"     </a>",
"     )",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Children:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Analgesic: Oral, rectal: 10-15 mg/kg/dose every 4-6 hours; maximum dose: 4 g/day",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Anti-inflammatory: Oral: Initial: 60-90 mg/kg/day in divided doses; usual maintenance: 80-100 mg/kg/day divided every 6-8 hours; monitor serum concentrations",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Antiplatelet effects: Adequate pediatric studies have not been performed; pediatric dosage is derived from adult studies and clinical experience and is not well established; suggested doses have ranged from 1-5 mg/kg/day (Monagle, 2008) to 5-10 mg/kg/day given as a single daily dose. Doses are typically rounded to a convenient amount (eg,",
"     <sup>",
"      1",
"     </sup>",
"     /",
"     <sub>",
"      2",
"     </sub>",
"     of 81 mg tablet).",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;text-align:justify;\">",
"     Mechanical prosthetic heart valves: 1-5 mg/kg/day given as a single daily dose (used in combination with an oral anticoagulant in children who have systemic embolism despite adequate oral anticoagulation therapy and used in combination with low-dose anticoagulation when full-dose oral anticoagulation is contraindicated) has been previously recommended (Monagle, 2004); current recommendations do not include specific dose recommendations (Monagle, 2008)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;text-align:justify;\">",
"     Blalock-Taussig shunts, primary prophylaxis: 1-5 mg/kg/day given as a single daily dose (Monagle, 2008)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;text-align:justify;\">",
"     Patients following Fontan surgery, primary prophylaxis: 1-5 mg/kg/day given as a single daily dose (Monagle, 2008)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;text-align:justify;\">",
"     Arterial ischemic stroke, recurrent: 1-5 mg/kg/day given as a single daily dose after anticoagulation therapy has been discontinued (Monagle, 2008)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Kawasaki disease: Oral: 80-100 mg/kg/day divided every 6 hours for up to 14 days (until fever resolves for at least 48 hours); then decrease dose to 3-5 mg/kg/day once daily. In patients without coronary artery abnormalities, give lower dose for 6-8 weeks. In patients with coronary artery abnormalities, low-dose aspirin should be continued indefinitely (in addition to therapy with warfarin) (Monagle, 2008)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Adults:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Analgesic and antipyretic: Oral, rectal: 325-1000 mg every 4-6 hours up to 4 g/day",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Anti-inflammatory: Oral: Initial: 2.4-3.6 g/day in divided doses; usual maintenance: 3.6-5.4 g/day; monitor serum concentrations",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Suspected acute MI: Oral: Initial: 160-162.5 mg as soon as MI is suspected; then 160-162.5 mg once daily for 30 days post MI; then consider further aspirin treatment",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     MI prophylaxis: Oral: 75-325 mg once daily (continue indefinitely)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Prevention of stroke following ischemic stroke or TIA: Oral: 50-325 mg once daily (continue indefinitely)",
"    </p>",
"   </div>",
"   <div class=\"block foc drugH1Div\" id=\"F137065\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosage Forms: U.S.",
"    </span>",
"    <p style=\"text-indent:0em;text-align:justify;display:inline\">",
"     Excipient information presented when available (limited, particularly for generics); consult specific product labeling.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Caplet, oral: 500 mg",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Bayer&reg; Aspirin Extra Strength: 500 mg",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Bayer&reg; Genuine Aspirin: 325 mg",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Bayer&reg; Women's Low Dose Aspirin: 81 mg [contains elemental calcium 300 mg]",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Caplet, oral [buffered]:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Ascriptin&reg; Maximum Strength: 500 mg [contains aluminum hydroxide, calcium carbonate, magnesium hydroxide]",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Bayer&reg; Plus Extra Strength: 500 mg [contains calcium carbonate]",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Caplet, enteric coated, oral:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Bayer&reg; Aspirin Regimen Regular Strength: 325 mg",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Gum, chewing, oral:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Aspergum&reg;: 227 mg (12s) [cherry flavor]",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Aspergum&reg;: 227 mg (12s) [orange flavor]",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Suppository, rectal: 300 mg (12s); 600 mg (12s)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Tablet, oral: 325 mg",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Aspercin: 325 mg",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Aspirtab: 325 mg",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Bayer&reg; Genuine Aspirin: 325 mg",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Tablet, oral [buffered]: 325 mg",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Ascriptin&reg; Regular Strength: 325 mg [contains aluminum hydroxide, calcium carbonate, magnesium hydroxide]",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Buffasal: 325 mg [contains magnesium oxide]",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Bufferin&reg;: 325 mg [contains calcium carbonate, magnesium carbonate, magnesium oxide]",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Bufferin&reg; Extra Strength: 500 mg [contains calcium carbonate, magnesium carbonate, magnesium oxide]",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Buffinol: 324 mg [sugar free; contains magnesium oxide]",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Tri-Buffered Aspirin: 325 mg [contains calcium carbonate, magnesium carbonate, magnesium oxide]",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Tablet, chewable, oral: 81 mg",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Bayer&reg; Aspirin Regimen Children's: 81 mg [cherry flavor]",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Bayer&reg; Aspirin Regimen Children's: 81 mg [orange flavor]",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     St Joseph&reg; Adult Aspirin: 81 mg",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Tablet, enteric coated, oral: 81 mg, 325 mg, 650 mg",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Aspir-low: 81 mg",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Bayer&reg; Aspirin Regimen Adult Low Strength: 81 mg",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Ecotrin&reg;: 325 mg",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Ecotrin&reg; Arthritis Strength: 500 mg",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Ecotrin&reg; Low Strength: 81 mg",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Halfprin&reg;: 81 mg, 162 mg",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     St Joseph&reg; Adult Aspirin: 81 mg",
"    </p>",
"   </div>",
"   <div class=\"block geq drugH1Div\" id=\"F137050\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Generic Equivalent Available: U.S.",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Yes: Excludes gum",
"    </p>",
"   </div>",
"   <div class=\"block adm drugH1Div\" id=\"F1051179\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Administration",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Oral: Administer with water, food, or milk to decrease GI upset. Do not crush or chew enteric coated tablets; these preparations should be swallowed whole.",
"    </p>",
"   </div>",
"   <div class=\"block sta drugH1Div\" id=\"F1051170\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Stability",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Keep suppositories in refrigerator, do not freeze; hydrolysis of aspirin occurs upon exposure to water or moist air, resulting in salicylate and acetate; acetate possesses a vinegar-like odor; do not use if a strong odor is present",
"    </p>",
"   </div>",
"   <div class=\"block use drugH1Div\" id=\"F1051178\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Use",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Treatment of mild to moderate pain, inflammation and fever; adjunctive treatment of Kawasaki disease; prevention of vascular mortality during suspected acute MI; prevention of recurrent MI; prevention of MI in patients with angina; prevention of recurrent stroke and mortality following TIA or stroke; management of rheumatoid arthritis, rheumatic fever, osteoarthritis, and gout (high dose); adjunctive therapy in revascularization procedures (coronary artery bypass graft, percutaneous transluminal coronary angioplasty, carotid endarterectomy)",
"    </p>",
"   </div>",
"   <div class=\"block mst drugH1Div\" id=\"F137154\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Medication Safety Issues",
"    </span>",
"    <div class=\"collapsible\">",
"     <span class=\"collapsible-title\">",
"      Sound-alike/look-alike issues:",
"     </span>",
"     <div class=\"collapsible-wrap\">",
"      <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"       Aspirin may be confused with Afrin&reg;",
"      </p>",
"      <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"       Ascriptin&reg; may be confused with Aricept&reg;",
"      </p>",
"      <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"       Ecotrin&reg; may be confused with Edecrin&reg;, Epogen&reg;",
"      </p>",
"      <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"       Halfprin&reg; may be confused with Haltran&reg;",
"      </p>",
"      <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"       ZORprin&reg; may be confused with Zyloprim&reg;",
"      </p>",
"     </div>",
"    </div>",
"    <div class=\"collapsible\">",
"     <span class=\"collapsible-title\">",
"      International issues:",
"     </span>",
"     <div class=\"collapsible-wrap\">",
"      <p style=\"text-indent:-2em;margin-left:4em;\">",
"       Cartia [multiple international markets] may be confused with Cartia XT brand name for diltiazem [U.S.]",
"      </p>",
"     </div>",
"    </div>",
"    <div class=\"collapsible\">",
"     <span class=\"collapsible-title\">",
"      BEERS Criteria medication:",
"     </span>",
"     <div class=\"collapsible-wrap\">",
"      <p style=\"text-indent:-2em;margin-left:4em;\">",
"       This drug may be potentially inappropriate for use in geriatric patients (Quality of evidence - moderate; Strength of recommendation - strong).",
"      </p>",
"     </div>",
"    </div>",
"   </div>",
"   <div class=\"block arm drugH1Div\" id=\"F137152\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Adverse Reactions",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     As with all drugs which may affect hemostasis, bleeding is associated with aspirin. Hemorrhage may occur at virtually any site. Risk is dependent on multiple variables including dosage, concurrent use of multiple agents which alter hemostasis, and patient susceptibility. Many adverse effects of aspirin are dose related, and are extremely rare at low dosages. Other serious reactions are idiosyncratic, related to allergy or individual sensitivity.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;margin-top:2em;text-align:justify;\">",
"     Cardiovascular: Dysrhythmias, edema, hypotension, tachycardia",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Central nervous system: Agitation, cerebral edema, coma, confusion, dizziness, fatigue, headache, hyperthermia, insomnia, lethargy, nervousness",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Dermatologic: Angioedema, rash, urticaria",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Endocrine &amp; metabolic: Acidosis, dehydration, hyperglycemia, hyperkalemia, hypernatremia (buffered forms), hypoglycemia (children)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Gastrointestinal: Duodenal ulcers, dyspepsia, epigastric discomfort, gastrointestinal ulceration, gastric erosions, gastric erythema, heartburn, nausea, stomach pain, vomiting",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Hematologic: Anemia, bleeding, coagulopathy, disseminated intravascular coagulation (DIC), hemolytic anemia, iron-deficiency anemia, prothrombin times prolonged, thrombocytopenia",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Hepatic: Hepatitis (reversible), hepatotoxicity, transaminases increased",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Neuromuscular &amp; skeletal: Acetabular bone destruction (OA), rhabdomyolysis, weakness",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Otic: Hearing loss, tinnitus",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Renal: BUN increased, interstitial nephritis, papillary necrosis, proteinuria, renal failure (including cases caused by rhabdomyolysis), serum creatinine increased",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Respiratory: Asthma, bronchospasm, dyspnea, hyperpnea, laryngeal edema, noncardiogenic pulmonary edema, respiratory alkalosis, tachypnea",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Miscellaneous: Anaphylaxis, low birth weight, peripartum bleeding, prolonged pregnancy and labor, Reye's syndrome, stillbirths",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Postmarketing and/or case reports: Cholestatic jaundice, colitis, colonic ulceration, conduction defect and atrial fibrillation (toxicity), coronary artery spasm, delirium, esophageal stricture, esophagitis with esophageal ulcer, esophageal hematoma, ischemic brain infarction, oral mucosal ulcers (aspirin-containing chewing gum), periorbital edema, rectal stenosis (suppository), rhinosinusitis",
"    </p>",
"   </div>",
"   <div class=\"block coi drugH1Div\" id=\"F1051182\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Contraindications",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Hypersensitivity to salicylates or any component; history of asthma, urticaria, or allergic-type reaction to aspirin, or other NSAIDs; patients with the \"aspirin triad\" [asthma, rhinitis (with or without nasal polyps), and aspirin intolerance] (fatal asthmatic and anaphylactoid reactions may occur in these patients); bleeding disorders; hepatic failure",
"    </p>",
"   </div>",
"   <div class=\"block pre drugH1Div\" id=\"F1051165\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Precautions",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Use with caution in patients with impaired renal function, erosive gastritis, peptic ulcer, gout, platelet and bleeding disorders",
"    </p>",
"   </div>",
"   <div class=\"block war drugH1Div\" id=\"F1051164\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Warnings",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Do not use aspirin in children and teenagers who have or who are recovering from chickenpox or flu symptoms (due to the association with Reye's syndrome); when using aspirin, changes in behavior (along with nausea and vomiting) may be an early sign of Reye's syndrome; instruct patients and caregivers to contact their healthcare provider if these symptoms occur. Caplet may contain tartrazine which may cause allergic reactions in susceptible individuals",
"    </p>",
"   </div>",
"   <div class=\"block cyt drugH1Div\" id=\"F137138\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Metabolism/Transport Effects",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     <b>",
"      Substrate",
"     </b>",
"     of CYP2C9 (minor);",
"     <b>",
"      Note:",
"     </b>",
"     Assignment of Major/Minor substrate status based on clinically relevant drug interaction potential",
"    </p>",
"   </div>",
"   <div class=\"block dri drugH1Div\" id=\"F137059\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Drug Interactions",
"    </span>",
"    <br/>",
"    <br/>",
"    <div class=\"lexi\" id=\"lexiInteractAddInfo\">",
"     (For additional information:",
"     <a class=\"dip\" href=\"./drug-interaction\" target=\"_blank\">",
"      Launch Lexi-Interact&trade; Drug Interactions Program",
"     </a>",
"     )",
"    </div>",
"    <div class=\"lexi\" id=\"lexiInteractImgB\">",
"     <img border=\"0\" height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"    </div>",
"    <div class=\"clear\">",
"    </div>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     ACE Inhibitors: Salicylates may diminish the antihypertensive effect of ACE Inhibitors. They may also diminish other beneficial pharmacodynamic effects desired for the treatment of CHF.  The effects are likely dose-related.  100 mg doses aspirin appear to cause no problems, whereas 300 mg doses appear to significantly affect ACE Inhibitor efficacy.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Agents with Antiplatelet Properties (e.g., P2Y12 inhibitors, NSAIDs, SSRIs, etc.): May enhance the adverse/toxic effect of Salicylates. Increased risk of bleeding may result.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Alendronate: Aspirin may enhance the adverse/toxic effect of Alendronate. Specifically gastrointestinal adverse events.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Ammonium Chloride: May increase the serum concentration of Salicylates.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Anticoagulants: Salicylates may enhance the anticoagulant effect of Anticoagulants.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Antidepressants (Tricyclic, Tertiary Amine): May enhance the antiplatelet effect of Aspirin.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Calcium Channel Blockers (Nondihydropyridine): May enhance the anticoagulant effect of Salicylates.",
"     <b>",
"      Exceptions:",
"     </b>",
"     Bepridil [Off Market].",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Carbonic Anhydrase Inhibitors: Salicylates may enhance the adverse/toxic effect of Carbonic Anhydrase Inhibitors. Salicylate toxicity might be enhanced by this same combination.",
"     <b>",
"      Exceptions:",
"     </b>",
"     Brinzolamide; Dorzolamide.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Collagenase (Systemic): Agents with Antiplatelet Properties may enhance the adverse/toxic effect of Collagenase (Systemic). Specifically, the risk of injection site bruising and/or bleeding may be increased.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Corticosteroids (Systemic): Salicylates may enhance the adverse/toxic effect of Corticosteroids (Systemic). These specifically include gastrointestinal ulceration and bleeding. Corticosteroids (Systemic) may decrease the serum concentration of Salicylates. Withdrawal of corticosteroids may result in salicylate toxicity.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Dabigatran Etexilate: Agents with Antiplatelet Properties may enhance the anticoagulant effect of Dabigatran Etexilate. Agents with Antiplatelet Properties may increase the serum concentration of Dabigatran Etexilate. This mechanism applies specifically to clopidogrel.  Management: Increase monitoring for signs/symptoms of bleeding. The Canadian product monograph for dabigatran specifically recommends avoiding concomitant use with GIIb/IIIa inhibitors or ticlopidine, or with aspirin used for stroke prevention in atrial fibrillation.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Dasatinib: May enhance the anticoagulant effect of Agents with Antiplatelet Properties.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Divalproex: Salicylates may increase the serum concentration of Divalproex.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Drotrecogin Alfa (Activated): Salicylates may enhance the adverse/toxic effect of Drotrecogin Alfa (Activated). Bleeding may occur.  Management: Weigh potential benefits of drotrecogin against increased bleeding risk in patients who have received  platelet inhibitors including aspirin (over 650 mg daily within 1 week). Monitor for bleeding and stop infusion if clinically important bleeding occurs.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Floctafenine: May enhance the adverse/toxic effect of Aspirin. An increased risk of bleeding may be associated with use of this combination. Floctafenine may diminish the cardioprotective effect of Aspirin.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Ginkgo Biloba: May enhance the anticoagulant effect of Salicylates. Management: Consider alternatives to this combination of agents. Monitor for signs and symptoms of bleeding (especially intracranial bleeding) if salicylates are used in combination with ginkgo biloba.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Glucosamine: May enhance the antiplatelet effect of Agents with Antiplatelet Properties.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Heparin: Aspirin may enhance the anticoagulant effect of Heparin.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Herbs (Anticoagulant/Antiplatelet Properties) (eg, Alfalfa, Anise, Bilberry): May enhance the adverse/toxic effect of Salicylates. Bleeding may occur.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Hyaluronidase: Salicylates may diminish the therapeutic effect of Hyaluronidase.  Management: Patients receiving salicylates (particularly at larger doses) may not experience the desired clinical response to standard doses of hyaluronidase.  Larger doses of hyaluronidase may be required.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Hypoglycemic Agents: Salicylates may enhance the hypoglycemic effect of Hypoglycemic Agents.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Ibritumomab: Agents with Antiplatelet Properties may enhance the adverse/toxic effect of Ibritumomab. Both agents may contribute to impaired platelet function and an increased risk of bleeding.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Influenza Virus Vaccine (Live/Attenuated): May enhance the adverse/toxic effect of Salicylates. Specifically, Reye's syndrome may develop.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Ketorolac (Nasal): May enhance the adverse/toxic effect of Aspirin. An increased risk of bleeding may be associated with use of this combination. Ketorolac (Nasal) may diminish the cardioprotective effect of Aspirin.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Ketorolac (Systemic): May enhance the adverse/toxic effect of Aspirin. An increased risk of bleeding may be associated with use of this combination. Ketorolac (Systemic) may diminish the cardioprotective effect of Aspirin.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Loop Diuretics: Salicylates may diminish the diuretic effect of Loop Diuretics. Loop Diuretics may increase the serum concentration of Salicylates.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Methotrexate: Salicylates may increase the serum concentration of Methotrexate. Salicylate doses used for prophylaxis of cardiovascular events are not likely to be of concern.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Multivitamins/Minerals (with ADEK, Folate, Iron): May enhance the antiplatelet effect of Aspirin. Aspirin may decrease the serum concentration of Multivitamins/Minerals (with ADEK, Folate, Iron). Specifically, aspirin may decrease absorption of ascorbic acid.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     NSAID (COX-2 Inhibitor): Aspirin may enhance the adverse/toxic effect of NSAID (COX-2 Inhibitor).  Management: Concurrent use of aspirin at doses beyond cardioprotective levels is not recommended.  While concurrent use of low-dose aspirin with a COX-2 inhibitor is permissable, patients should be monitored closely for signs/symptoms of GI ulceration/bleeding.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     NSAID (Nonselective): May enhance the adverse/toxic effect of Salicylates. An increased risk of bleeding may be associated with use of this combination. NSAID (Nonselective) may diminish the cardioprotective effect of Salicylates. Salicylates may decrease the serum concentration of NSAID (Nonselective).",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Omacetaxine: Aspirin may enhance the adverse/toxic effect of Omacetaxine. Specifically, the risk for bleeding-related events may be increased.  Management: Avoid concurrent use of aspirin with omacetaxine in patients with a platelet count of less than 50,000/uL.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Omega-3 Fatty Acids: May enhance the antiplatelet effect of Agents with Antiplatelet Properties.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Pentosan Polysulfate Sodium: May enhance the adverse/toxic effect of Agents with Antiplatelet Properties. Specifically, the risk of bleeding may be increased by concurrent use of these agents.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Pentoxifylline: May enhance the antiplatelet effect of Agents with Antiplatelet Properties.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Potassium Acid Phosphate: May increase the serum concentration of Salicylates.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     PRALAtrexate: Salicylates may increase the serum concentration of PRALAtrexate. Salicylate doses used for prophylaxis of cardiovascular events are unlikely to be of concern.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Probenecid: Salicylates may diminish the therapeutic effect of Probenecid.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Prostacyclin Analogues: May enhance the antiplatelet effect of Agents with Antiplatelet Properties.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Rivaroxaban: Agents with Antiplatelet Properties may enhance the anticoagulant effect of Rivaroxaban.  Management: Avoid concurrent use of clopidogrel with rivaroxaban unless the anticipated benefits outweigh the risks of bleeding.  Avoid concurrent use of rivaroxaban with other antiplatelet agents whenever possible.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Salicylates: May enhance the anticoagulant effect of other Salicylates.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Selective Serotonin Reuptake Inhibitors: May enhance the antiplatelet effect of Aspirin.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Serotonin/Norepinephrine Reuptake Inhibitors: May enhance the antiplatelet effect of Aspirin.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Thrombolytic Agents: Salicylates may enhance the adverse/toxic effect of Thrombolytic Agents. An increased risk of bleeding may occur.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Ticagrelor: Aspirin may enhance the antiplatelet effect of Ticagrelor. Aspirin may diminish the therapeutic effect of Ticagrelor. More specifically, the benefits of ticagrelor relative to clopidogrel may be diminished in patients receiving daily aspirin doses greater than 100-150 mg daily.  Management: Avoid daily aspirin doses greater than 100 mg in patients receiving ticagrelor.  Canadian recommendations are to avoid daily aspirin doses greater than 150 mg.  Daily low-dose aspirin (U.S.: 75-100 mg; Canada: 75-150 mg) is recommended.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Tiludronate: Aspirin may decrease the serum concentration of Tiludronate.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Tipranavir: May enhance the antiplatelet effect of Agents with Antiplatelet Properties.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Tositumomab and Iodine I 131 Tositumomab: Agents with Antiplatelet Properties may enhance the adverse/toxic effect of Tositumomab and Iodine I 131 Tositumomab. Specifically, the risk of bleeding-related adverse events may be increased.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Treprostinil: May enhance the adverse/toxic effect of Salicylates. Bleeding may occur.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Valproic Acid: Salicylates may increase the serum concentration of Valproic Acid.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Varicella Virus-Containing Vaccines: Salicylates may enhance the adverse/toxic effect of Varicella Virus-Containing Vaccines. Reye's Syndrome may develop.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Vitamin E: May enhance the antiplatelet effect of Agents with Antiplatelet Properties.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Vitamin K Antagonists (eg, warfarin): Salicylates may enhance the anticoagulant effect of Vitamin K Antagonists.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"   </div>",
"   <div class=\"block foi drugH1Div\" id=\"F1051184\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Food Interactions",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Aspirin may increase the renal excretion of vitamin C and may decrease serum folate levels; some suggest increasing the dietary intake of foods that are high in vitamin C and folic acid",
"    </p>",
"   </div>",
"   <div class=\"block pri drugH1Div\" id=\"F137075\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pregnancy Implications",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Salicylates have been noted to cross the placenta and enter fetal circulation. Adverse effects reported in the fetus include mortality, intrauterine growth retardation, salicylate intoxication, bleeding abnormalities, and neonatal acidosis. Use of aspirin close to delivery may cause premature closure of the ductus arteriosus. Adverse effects reported in the mother include anemia, hemorrhage, prolonged gestation, and prolonged labor (&Oslash;stensen, 1998). Aspirin has been used for the prevention of pre-eclampsia; however, the ACOG currently recommends that it not be used in low-risk women (ACOG, 2002). Low-dose aspirin is used to treat complications resulting from antiphospholipid syndrome in pregnancy (either primary or secondary to SLE) (Carp, 2004; Guyatt, 2012; Tincani, 2003). In general, low doses during pregnancy needed for the treatment of certain medical conditions have not been shown to cause fetal harm, however, discontinuing therapy prior to delivery is recommended (&Oslash;stensen, 2006). Use of safer agents for routine management of pain or headache should be considered.",
"    </p>",
"   </div>",
"   <div class=\"block mop drugH1Div\" id=\"F1051173\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Monitoring Parameters",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Serum salicylate concentration with chronic use; may not be necessary in Kawasaki disease;",
"     <b>",
"      Note:",
"     </b>",
"     Decreased aspirin absorption and increased salicylate clearance has been observed in children with acute Kawasaki disease; these patients rarely achieve therapeutic serum salicylate concentrations; thus, monitoring of serum salicylate concentrations is not necessary in most of these children (Pickering, 2009).",
"    </p>",
"   </div>",
"   <div class=\"block rer drugH1Div\" id=\"F1051177\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Reference Range",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Therapeutic levels:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Anti-inflammatory effect: 150-300 mcg/mL",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Analgesic and antipyretic effect: 30-50 mcg/mL",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Timing of serum samples: Peak levels usually occur 2 hours after normal doses but may occur 6-24 hours after acute toxic ingestion.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Salicylate serum concentrations correlate with the pharmacological actions and adverse effects observed. See table.",
"    </p>",
"    <table border=\"1\" frame=\"border\" rules=\"all\">",
"     <caption style=\"text-align:center;\">",
"      Serum Salicylate: Clinical Correlations",
"     </caption>",
"     <col align=\"center\" width=\"125\">",
"     </col>",
"     <col align=\"left\" width=\"155\">",
"     </col>",
"     <col align=\"left\" width=\"200\">",
"     </col>",
"     <thead valign=\"middle\">",
"      <tr>",
"       <th align=\"center\" valign=\"middle\">",
"        <p style=\"text-indent:0em;\">",
"         Serum Salicylate Concentration",
"        </p>",
"        <p style=\"text-indent:0em;\">",
"         (mcg/mL)",
"        </p>",
"       </th>",
"       <th align=\"center\" valign=\"middle\">",
"        <p style=\"text-indent:0em;\">",
"         Desired Effects",
"        </p>",
"       </th>",
"       <th align=\"center\" valign=\"middle\">",
"        <p style=\"text-indent:0em;\">",
"         Adverse Effects / Intoxication",
"        </p>",
"       </th>",
"      </tr>",
"     </thead>",
"     <tbody valign=\"top\">",
"      <tr>",
"       <td align=\"center\" valign=\"middle\">",
"        <p style=\"text-indent:0em;\">",
"         &sim;100",
"        </p>",
"       </td>",
"       <td align=\"left\">",
"        <p style=\"text-indent:0em;\">",
"         Antiplatelet",
"        </p>",
"        <p style=\"text-indent:0em;\">",
"         Antipyresis",
"        </p>",
"        <p style=\"text-indent:0em;\">",
"         Analgesia",
"        </p>",
"       </td>",
"       <td align=\"left\">",
"        <p style=\"text-indent:0em;\">",
"         GI intolerance and bleeding, hypersensitivity, hemostatic defects",
"        </p>",
"       </td>",
"      </tr>",
"      <tr>",
"       <td align=\"center\" valign=\"middle\">",
"        <p style=\"text-indent:0em;\">",
"         150-300",
"        </p>",
"       </td>",
"       <td align=\"left\">",
"        <p style=\"text-indent:0em;\">",
"         Anti-inflammatory",
"        </p>",
"       </td>",
"       <td align=\"left\">",
"        <p style=\"text-indent:0em;\">",
"         Mild salicylism",
"        </p>",
"       </td>",
"      </tr>",
"      <tr>",
"       <td align=\"center\" valign=\"middle\">",
"        <p style=\"text-indent:0em;\">",
"         250-400",
"        </p>",
"       </td>",
"       <td align=\"left\" valign=\"middle\">",
"        <p style=\"text-indent:0em;\">",
"         Treatment of rheumatic fever",
"        </p>",
"       </td>",
"       <td align=\"left\">",
"        <p style=\"text-indent:0em;\">",
"         Nausea/vomiting, hyperventilation, salicylism, flushing, sweating, thirst, headache, diarrhea, and tachycardia",
"        </p>",
"       </td>",
"      </tr>",
"      <tr>",
"       <td align=\"center\" valign=\"middle\">",
"        <p style=\"text-indent:0em;\">",
"         &gt;400-500",
"        </p>",
"       </td>",
"       <td align=\"left\">",
"       </td>",
"       <td align=\"left\">",
"        <p style=\"text-indent:0em;\">",
"         Respiratory alkalosis, hemorrhage, excitement, confusion, asterixis, pulmonary edema, convulsions, tetany, metabolic acidosis, fever, coma, cardiovascular collapse, renal and respiratory failure",
"        </p>",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"block pha drugH1Div\" id=\"F1051163\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Mechanism of Action",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Inhibits prostaglandin synthesis, acts on the hypothalamus heat-regulating center to reduce fever, blocks prostaglandin synthetase action which prevents formation of the platelet-aggregating substance thromboxane A",
"     <sub>",
"      2",
"     </sub>",
"    </p>",
"   </div>",
"   <div class=\"block phk drugH1Div\" id=\"F1051181\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pharmacokinetics (Adult data unless noted)",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Absorption: From the stomach and small intestine",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Distribution: Readily distributes into most body fluids and tissues; hydrolyzed to salicylate (active) by esterases in the GI mucosa, red blood cells, synovial fluid and blood",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Metabolism: Primarily by hepatic microsomal enzymes",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Half-life: 15-20 minutes; metabolic pathways are saturable such that salicylate half-life is dose-dependent ranging from 3 hours at lower doses (300-600 mg), 5-6 hours (after 1 g) and 10 hours with higher doses",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Time to peak serum concentration: Salicylate: ~1-2 hours",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Elimination: Renal as salicylate and conjugated metabolites",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Dialysis: Dialyzable: 50% to 100%",
"    </p>",
"   </div>",
"   <div class=\"block pai drugH1Div\" id=\"F1051172\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Patient Information",
"    </span>",
"    <p>",
"     (For additional information",
"     <a class=\"drug drug_patient\" href=\"UTD.htm?6/12/6342?source=see_link\">",
"      see \"Aspirin: Patient drug information\"",
"     </a>",
"     )",
"    </p>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Avoid alcohol; watch for bleeding gums or signs of GI bleeding, (bright red blood in emesis or stool, coffee ground-like emesis, black tarry stools); notify physician if ringing in the ears, persistent GI pain, GI bleeding, or changes in behavior (along with nausea and vomiting) occur",
"    </p>",
"   </div>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <div class=\"reference\">",
"      ACOG Committee on Obstetric Practice, &ldquo;ACOG Practice Bulletin. Diagnosis and Management of Preeclampsia and Eclampsia. Number 33, January 2002. American College of Obstetricians and Gynecologists,&rdquo;",
"      <i>",
"       Int J Gynaecol Obstet",
"      </i>",
"      , 2002, 77(1):67-75.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?19/10/19624/abstract-text/12094777/pubmed\" id=\"12094777\" target=\"_blank\">",
"        12094777",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Bar-Oz B, Bulkowstein M, Benyamini L, et al, &ldquo;Use of Antibiotic and Analgesic Drugs During Lactation,&rdquo;",
"      <i>",
"       Drug Saf",
"      </i>",
"      , 2003, 26(13):925-35.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?19/10/19624/abstract-text/14583068/pubmed\" id=\"14583068\" target=\"_blank\">",
"        14583068",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Capone ML, Sciulli MG, Tacconelli S, et al, &ldquo;Pharmacodynamic Interaction of Naproxen With Low-Dose Aspirin in Healthy Subjects,&rdquo;",
"      <i>",
"       J Am Coll Cardiol",
"      </i>",
"      , 2005, 45(8):1295-1301.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?19/10/19624/abstract-text/15837265/pubmed\" id=\"15837265\" target=\"_blank\">",
"        15837265",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Carp HJ, &ldquo;Antiphospholipid Syndrome in Pregnancy,&rdquo;",
"      <i>",
"       Curr Opin Obstet Gynecol",
"      </i>",
"      , 2004, 16(2):129-35.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?19/10/19624/abstract-text/15017341/pubmed\" id=\"15017341\" target=\"_blank\">",
"        15017341",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Catella-Lawson F, Reilly MP, Kapoor SC, et al, &ldquo;Cyclooxygenase Inhibitors and the Antiplatelet Effects of Aspirin,&rdquo;",
"      <i>",
"       N Engl J Med",
"      </i>",
"      , 2001, 345(25):1809-17.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?19/10/19624/abstract-text/11752357/pubmed\" id=\"11752357\" target=\"_blank\">",
"        11752357",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Cryer B, Verlin RG, Cooper SA, et al, &ldquo;Double-Blind, Randomized, Parallel, Placebo-Controlled Study Of Ibuprofen Effects On Thromboxane B2 Concentrations In Aspirin-Treated Healthy Adult Volunteers,&rdquo;",
"      <i>",
"       Clin Ther",
"      </i>",
"      , 2005, 27 (2):185-191.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?19/10/19624/abstract-text/15811481/pubmed\" id=\"15811481\" target=\"_blank\">",
"        15811481",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Guyatt GH, Akl EA, Crowther M, et al, &ldquo;Executive Summary: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines,&rdquo;",
"      <i>",
"       Chest",
"      </i>",
"      , 2012, 141(2 Suppl):7-47.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?19/10/19624/abstract-text/22315257/pubmed\" id=\"22315257\" target=\"_blank\">",
"        22315257",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Hathaway WE, &ldquo;Use of Antiplatelet Agents in Pediatric Hypercoagulable States,&rdquo;",
"      <i>",
"       Am J Dis Child",
"      </i>",
"      , 1984, 138(3):301-4.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?19/10/19624/abstract-text/6702778/pubmed\" id=\"6702778\" target=\"_blank\">",
"        6702778",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Levy G, \"Clinical Pharmacokinetics of Aspirin,\"",
"      <i>",
"       Pediatrics",
"      </i>",
"      , 1978, 62(5 Pt 2 Suppl):867-72.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?19/10/19624/abstract-text/724339/pubmed\" id=\"724339\" target=\"_blank\">",
"        724339",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Monagle P, Chalmers E, Chan A, et al, \"Antithrombotic Therapy in Neonates and Children: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition),\"",
"      <i>",
"       Chest",
"      </i>",
"      , 2008, 133(6 Suppl):887S-968S.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?19/10/19624/abstract-text/18574281/pubmed\" id=\"18574281\" target=\"_blank\">",
"        18574281",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Monagle P, Chan A, Massicotte P, et al, \"Antithrombotic Therapy in Children: The Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy,\"",
"      <i>",
"       Chest",
"      </i>",
"      , 2004, 126(3 Suppl):645S-687S.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?19/10/19624/abstract-text/15383489/pubmed\" id=\"15383489\" target=\"_blank\">",
"        15383489",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      &Oslash;stensen M, Khamashta M, Lockshin M, \"Anti-inflammatory and Immunosuppressive Drugs and Reproduction,\"",
"      <i>",
"       Arthritis Res Ther",
"      </i>",
"      , 2006, 8(3):209.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?19/10/19624/abstract-text/16712713/pubmed\" id=\"16712713\" target=\"_blank\">",
"        16712713",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      &Oslash;stensen M, &ldquo;Nonsteroidal Anti-inflammatory Drugs During Pregnancy,&rdquo;",
"      <i>",
"       Scand J Rheumatol Suppl",
"      </i>",
"      , 1998, 107:128-32.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?19/10/19624/abstract-text/9759151/pubmed\" id=\"9759151\" target=\"_blank\">",
"        9759151",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      <i>",
"       Red Book: 2009 Report of the Committee on Infectious Diseases",
"      </i>",
"      , 28th ed, Pickering LK, ed, Elk Grove Village IL: American Academy of Pediatrics, 2009, 360, 417.",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Spigset O and Hagg S, &ldquo;Analgesics and Breast-Feeding: Safety Considerations,&rdquo;",
"      <i>",
"       Paediatr Drugs",
"      </i>",
"      , 2000, 2(3):223-38.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?19/10/19624/abstract-text/10937472/pubmed\" id=\"10937472\" target=\"_blank\">",
"        10937472",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Tincani A, Branch W, Levy RA, et al, &ldquo;Treatment of Pregnant Patients With Antiphospholipid Syndrome,&rdquo;",
"      <i>",
"       Lupus",
"      </i>",
"      , 2003, 12(7):524-9.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?19/10/19624/abstract-text/12892392/pubmed\" id=\"12892392\" target=\"_blank\">",
"        12892392",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      World Health Organization (WHO), \"Breastfeeding and Maternal Medication, Recommendations for Drugs in the Eleventh WHO Model List of Essential Drugs,\" 2013. Available at file://www.who.int/maternal_child_adolescent/documents/55732/en/index.html",
"     </div>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 12829 Version 43.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0602-61.234.146.186-F0BCE44B44-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f19_10_19624=[""].join("\n");
var outline_f19_10_19624=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F137093\">",
"      Brand Names: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F137094\">",
"      Brand Names: Canada",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1051174\">",
"      Therapeutic Category",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F12669217\">",
"      Dosing: Neonatal",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1051166\">",
"      Dosing: Usual",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F137065\">",
"      Dosage Forms: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F137050\">",
"      Generic Equivalent Available: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1051179\">",
"      Administration",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1051170\">",
"      Stability",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1051178\">",
"      Use",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F137154\">",
"      Medication Safety Issues",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F137152\">",
"      Adverse Reactions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1051182\">",
"      Contraindications",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1051165\">",
"      Precautions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1051164\">",
"      Warnings",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F137138\">",
"      Metabolism/Transport Effects",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F137059\">",
"      Drug Interactions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1051184\">",
"      Food Interactions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F137075\">",
"      Pregnancy Implications",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1051173\">",
"      Monitoring Parameters",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1051177\">",
"      Reference Range",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1051163\">",
"      Mechanism of Action",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1051181\">",
"      Pharmacokinetics (Adult data unless noted)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1051172\">",
"      Patient Information",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"DRUG_PED/12829\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"DRUG_PED/12829|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?23/39/24183\" title=\"Lexicomp clinical abbreviations\">",
"      Lexicomp clinical abbreviations",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_general\" href=\"UTD.htm?24/7/24698?source=related_link\">",
"      Aspirin: Drug information",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_patient\" href=\"UTD.htm?6/12/6342?source=related_link\">",
"      Aspirin: Patient drug information",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f19_10_19625="Role of imaging in the staging of non-small cell lung cancer";
var content_f19_10_19625=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"4\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Role of imaging in the staging of non-small cell lung cancer",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?19/10/19625/contributors\">",
"     Author",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?19/10/19625/contributors\">",
"     Paul Stark, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?19/10/19625/contributors\">",
"     Section Editors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?19/10/19625/contributors\">",
"     James R Jett, MD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?19/10/19625/contributors\">",
"     Nestor L Muller, MD, PhD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?19/10/19625/contributors\">",
"     Deputy Editors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?19/10/19625/contributors\">",
"     Helen Hollingsworth, MD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?19/10/19625/contributors\">",
"     Michael E Ross, MD",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?19/10/19625/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Feb 12, 2013.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;When a patient presents with suspected non-small cell lung cancer (NSCLC), multiple imaging tests are required [",
"    <a class=\"abstract\" href=\"UTD.htm?19/10/19625/abstract/1\">",
"     1",
"    </a>",
"    ]. Imaging aims to accomplish three goals:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      One goal is to help determine the disease stage. This includes characterizing the primary tumor and identifying lymph nodes and other abnormalities that are suspicious for metastatic disease.",
"     </li>",
"     <li>",
"      Another goal is to identify lesions that warrant tissue sampling. Sampling is necessary to confirm both the diagnosis and disease stage.",
"     </li>",
"     <li>",
"      The third goal is to assist in planning surgical or radiation therapy.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    The role of imaging in the staging of NSCLC is reviewed here. Choosing lesions for tissue sampling and other aspects of diagnosis and staging are discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?14/31/14841?source=see_link\">",
"     \"Diagnosis and staging of non-small cell lung cancer\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     TNM STAGING",
"    </span>",
"    &nbsp;&mdash;&nbsp;The staging of NSCLC is based upon the tumor node metastasis (TNM) staging system, which grades tumor characteristics (T), presence or absence of regional lymph node involvement (N), and presence or absence of distant metastasis (M) [",
"    <a class=\"abstract\" href=\"UTD.htm?19/10/19625/abstract/2-5\">",
"     2-5",
"    </a>",
"    ]. The combination of T, N, and M grades determines the overall disease stage (stage I through IV).",
"   </p>",
"   <p>",
"    The 7th edition of the TNM staging system (",
"    <a class=\"graphic graphic_table graphicRef80099 \" href=\"UTD.htm?36/41/37533\">",
"     table 1",
"    </a>",
"    ) is the most recent version, replacing the 6th edition (",
"    <a class=\"graphic graphic_table graphicRef74820 \" href=\"UTD.htm?19/43/20157\">",
"     table 2",
"    </a>",
"    ) as of January 1, 2010. The major change in the 7th edition is the reclassification of malignant pleural effusions and separate tumor nodule(s) (previously called satellite nodules). Other changes include new size cut-offs and new subdivisions of the T1 (into T1a and T1b), T2 (into T2a and T2b), and M1 (into M1a and M1b) descriptors (",
"    <a class=\"graphic graphic_table graphicRef68104 \" href=\"UTD.htm?13/4/13388\">",
"     table 3",
"    </a>",
"    ). The changes provide a more refined prognosis for patients with different stages of lung cancer.",
"   </p>",
"   <p>",
"    The 7th edition of the TNM staging system is used in this review. It is described in detail separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?43/21/44373?source=see_link\">",
"     \"Tumor node metastasis (TNM) staging system for non-small cell lung cancer\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h1\">",
"     IMAGING MODALITIES",
"    </span>",
"    &nbsp;&mdash;&nbsp;The imaging modalities that are commonly used in the staging of suspected NSCLC include chest radiography, computed tomography (CT), positron emission tomography (PET), integrated",
"    <span class=\"nowrap\">",
"     PET/CT,",
"    </span>",
"    magnetic resonance imaging (MRI), and radionuclide bone scanning [",
"    <a class=\"abstract\" href=\"UTD.htm?19/10/19625/abstract/6-11\">",
"     6-11",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h2\">",
"     Chest radiography",
"    </span>",
"    &nbsp;&mdash;&nbsp;Chest radiography alone is insufficient for staging because it cannot accurately detect lymph node metastases, chest wall invasion, or invasion of mediastinal structures. Nearly all patients undergo computed tomography (CT) of the chest, as described below.",
"   </p>",
"   <p>",
"    Despite their limited utility in staging, chest radiographs have an important role in the assessment of a lung nodule or mass. Comparing a current chest radiograph to prior radiographs is often the only way to determine whether a lung lesion is new, enlarging, or stable, since patients are more likely to have had a prior chest radiograph than any other type of chest imaging. A new or enlarging lesion is more likely to be lung cancer than a lesion whose size and appearance have been stable for years.",
"   </p>",
"   <p>",
"    Generally speaking, chest radiography is readily available, inexpensive, and provides a lot of information with a minimal effective radiation dose. The effective radiation dose is approximately 0.02 milliSievert (mSv) for a frontal chest radiograph and 0.06 mSv for a lateral chest radiograph [",
"    <a class=\"abstract\" href=\"UTD.htm?19/10/19625/abstract/12,13\">",
"     12,13",
"    </a>",
"    ]. The relevance of these doses is discussed below.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h2\">",
"     Computed tomography",
"    </span>",
"    &nbsp;&mdash;&nbsp;CT of the chest is performed in nearly all patients with suspected NSCLC [",
"    <a class=\"abstract\" href=\"UTD.htm?19/10/19625/abstract/14\">",
"     14",
"    </a>",
"    ], while some patients also undergo a CT of the brain and abdomen to assess for metastatic disease.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h3\">",
"     Technique",
"    </span>",
"    &nbsp;&mdash;&nbsp;A reconstructed slice thickness of 1.25 to 2.5 mm is typical of multislice CT of the chest, while a slice thickness of 10 mm is typical of CT of the brain. A properly performed CT scan of the chest should visualize all of the thoracic structures from the base of the neck to below the adrenal glands, including the chest wall. CT scans of the brain should visualize the head from the vertex through the base of the skull, including the brain, skull, eye sockets, and sinuses.",
"   </p>",
"   <p>",
"    Intravenous contrast material should be used for CT scans of both the chest and brain. With respect to CT scans of the chest, intravenous contrast material helps distinguish vascular structures from nonvascular normal and abnormal mediastinal structures. It also facilitates assessment of potential vascular involvement of the superior vena cava, pulmonary veins, pulmonary arteries, systemic mediastinal arterial structures, and cardiac structures. With respect to CT scans of the brain, intravenous contrast should be used to identify metastatic lesions that may otherwise remain undetected.",
"   </p>",
"   <p>",
"    Rapid sequential cine viewing of multiple helical CT sections enhances the clinician's ability to detect small abnormalities and differentiate tubular structures (eg, blood vessels) from spherical structures (eg, nodules). Thick-slice sliding maximum intensity projection imaging (ie, sliding MIP) is also helpful in differentiating nodules from vascular structures seen on end. Additional advantages of CT include densitometric analysis of nodules (facilitating the detection of fat, calcium, or enhancement after intravenous contrast material injection) and the ability to display images in axial, sagittal, coronal, or oblique planes with the help of multiplanar reformatting.",
"   </p>",
"   <p>",
"    The effective radiation dose for CT of the chest varies between 5 and 10 mSv, which is approximately 100 times more than that for chest frontal and lateral radiographs [",
"    <a class=\"abstract\" href=\"UTD.htm?19/10/19625/abstract/12\">",
"     12",
"    </a>",
"    ]. To put this into context, all individuals are exposed to natural background radiation of approximately 3 mSv per year [",
"    <a class=\"abstract\" href=\"UTD.htm?19/10/19625/abstract/15\">",
"     15",
"    </a>",
"    ]. Studies of atomic bomb survivors from Japan suggest that the risk of developing cancer increases when radiation exposure exceeds 50 mSv or 100 mSv. Whether the risk of cancer is increased with less radiation exposure is uncertain and controversial [",
"    <a class=\"abstract\" href=\"UTD.htm?19/10/19625/abstract/16\">",
"     16",
"    </a>",
"    ]. To minimize radiation exposure, follow-up CT of the chest can be performed using low radiation protocols, which provide effective radiation doses of only 0.5 to 1 mSv [",
"    <a class=\"abstract\" href=\"UTD.htm?19/10/19625/abstract/17,18\">",
"     17,18",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h3\">",
"     Tumor",
"    </span>",
"    &nbsp;&mdash;&nbsp;CT assessment of the following features is generally sufficient to designate a tumor as T1a, T1b, T2a, T2b, T3, or T4 (",
"    <a class=\"graphic graphic_table graphicRef80099 \" href=\"UTD.htm?36/41/37533\">",
"     table 1",
"    </a>",
"    ):",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Tumor size",
"     </li>",
"     <li>",
"      Presence or absence of separate tumor nodule(s)",
"     </li>",
"     <li>",
"      Presence or absence of atelectasis or obstructive pneumonia",
"     </li>",
"     <li>",
"      Possible invasion of adjacent structures",
"     </li>",
"     <li>",
"      Proximal extent of the tumor. Clinicians should be aware that the proximal extent of the tumor can only be estimated by CT. Bronchoscopy is required for confirmation.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    The following radiographs demonstrate the value of CT for tumor characterization:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      T1a lesions are &le;2 cm in diameter (",
"      <a class=\"graphic graphic_diagnosticimage graphicRef63489 \" href=\"UTD.htm?13/11/13491\">",
"       image 1",
"      </a>",
"      ), while T1b lesions are lesions that are &gt;2 cm but &le;3 cm in diameter. Both T1a and T1b lesions are surrounded by lung or visceral pleura, without evidence of invasion proximal to a lobar bronchus.",
"     </li>",
"     <li>",
"      T2a lesions are &gt;3 cm but &le;5 cm in diameter (",
"      <a class=\"graphic graphic_diagnosticimage graphicRef57134 \" href=\"UTD.htm?40/37/41566\">",
"       image 2",
"      </a>",
"      ), while T2b lesions are &gt;5 cm but &le;7 cm (",
"      <a class=\"graphic graphic_diagnosticimage graphicRef59036 \" href=\"UTD.htm?31/11/31935\">",
"       image 3",
"      </a>",
"      ). T2 lesions also include tumors of any size that invade the visceral pleura, extend beyond a lobar bronchus but are &ge;2 cm distal to the carina, or are associated with atelectasis or obstructive pneumonia that involves the hilum but does not encompass the entire lung.",
"     </li>",
"     <li>",
"      T3 lesions are &gt;7 cm in diameter. Alternatively, they can be tumors of any size that are characterized by invasion of the chest wall (",
"      <a class=\"graphic graphic_diagnosticimage graphicRef73744 \" href=\"UTD.htm?37/41/38558\">",
"       image 4",
"      </a>",
"      and",
"      <a class=\"graphic graphic_diagnosticimage graphicRef53784 \" href=\"UTD.htm?7/15/7423\">",
"       image 5",
"      </a>",
"      ), diaphragm, phrenic nerve (",
"      <a class=\"graphic graphic_diagnosticimage graphicRef71610 \" href=\"UTD.htm?28/16/28931\">",
"       image 6",
"      </a>",
"      ), mediastinal pleura, parietal pleura, or main bronchus &lt;2 cm from the carina without involving the carina (",
"      <a class=\"graphic graphic_diagnosticimage graphicRef56988 \" href=\"UTD.htm?9/59/10175\">",
"       image 7",
"      </a>",
"      ). T3 lesions can also be tumors of any size that are associated with separate tumor nodule(s) in the same lobe, or atelectasis or obstructive pneumonia of the entire lung.",
"     </li>",
"     <li>",
"      T4 lesions are tumors of any size that are associated with separate tumor nodule(s) in a different ipsilateral lobe or have extensive invasion of the mediastinum with involvement of the carina, heart, great vessels (",
"      <a class=\"graphic graphic_diagnosticimage graphicRef58664 \" href=\"UTD.htm?39/43/40626\">",
"       image 8",
"      </a>",
"      ), trachea, recurrent laryngeal nerve, esophagus (",
"      <a class=\"graphic graphic_diagnosticimage graphicRef64447 \" href=\"UTD.htm?39/53/40799\">",
"       image 9",
"      </a>",
"      ), vertebral bodies, or brachial plexus.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Additional imaging studies are usually unnecessary for tumor characterization. Positron emission tomography (PET) with 18-Flouro-2-deoxyglucose (FDG) may help distinguish tumor from peritumoral atelectasis, thus preventing overestimation of the tumor's size [",
"    <a class=\"abstract\" href=\"UTD.htm?19/10/19625/abstract/19\">",
"     19",
"    </a>",
"    ]. MRI is the best modality for determining the presence and extent of invasion of the chest wall, spine, or brachial plexus, as well as detecting transdiaphragmatic growth of the tumor [",
"    <a class=\"abstract\" href=\"UTD.htm?19/10/19625/abstract/20-22\">",
"     20-22",
"    </a>",
"    ]&nbsp;(",
"    <a class=\"graphic graphic_picture graphicRef71057 \" href=\"UTD.htm?14/17/14609\">",
"     picture 1",
"    </a>",
"    ). Transesophageal echocardiography may be useful for detecting mediastinal or vascular invasion in selected patients [",
"    <a class=\"abstract\" href=\"UTD.htm?19/10/19625/abstract/23,24\">",
"     23,24",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h3\">",
"     Lymph nodes",
"    </span>",
"    &nbsp;&mdash;&nbsp;Lymph node enlargement on CT (measured in the short axis) presumes lymph node metastasis in the context of a newly diagnosed or suspected NSCLC:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Most normal mediastinal lymph nodes are less than 10 mm [",
"      <a class=\"abstract\" href=\"UTD.htm?19/10/19625/abstract/25,26\">",
"       25,26",
"      </a>",
"      ], although normal subcarinal lymph nodes can reach a diameter of 13 to 15 mm. Nodes exceeding these sizes are more likely to contain malignant disease in patients with lung cancer. Overall, lymph nodes less than 10 mm in short axis contain tumor cells in less than 13 percent of patients. Lymph nodes between 10 and 15 mm in short axis have a 50 percent probability of containing tumor cells and lymph nodes exceeding 15 mm in short axis have a probability of more than 67 percent for tumor involvement.",
"     </li>",
"     <li>",
"      Normal lymph nodes are rarely seen in the retrocrural region, para-aortic region, or pericardial fat. Lymph nodes exceeding 8 mm in these regions should be considered suspicious.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Mediastinal lymph nodes are graded as N0, N1, N2, or N3 on the basis of the absence or presence (and location) of lymph node enlargement (",
"    <a class=\"graphic graphic_table graphicRef80099 \" href=\"UTD.htm?36/41/37533\">",
"     table 1",
"    </a>",
"    ). However, the assignment should be considered tentative, since the use of lymph node enlargement as a surrogate for malignant disease is imperfect. Metastatic disease can exist in normal size lymph nodes, while hyperplastic, benign lymph nodes can exceed 10 mm.",
"   </p>",
"   <p>",
"    According to a meta-analysis of 35 studies (5111 patients), CT predicts mediastinal lymph node metastasis with a sensitivity and specificity of 51 and 86 percent, respectively, in a population with a prevalence of 28 percent [",
"    <a class=\"abstract\" href=\"UTD.htm?19/10/19625/abstract/25\">",
"     25",
"    </a>",
"    ]. Thus, tissue sampling is required to confirm the presence or absence of regional lymph node involvement. This is discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?14/31/14841?source=see_link&amp;anchor=H5#H5\">",
"     \"Diagnosis and staging of non-small cell lung cancer\", section on 'Tissue sampling'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?14/31/14841?source=see_link&amp;anchor=H11#H11\">",
"     \"Diagnosis and staging of non-small cell lung cancer\", section on 'Approach to diagnosis and staging'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    A map of the thoracic lymph nodes is shown in the figure (",
"    <a class=\"graphic graphic_figure graphicRef73945 \" href=\"UTD.htm?19/28/19914\">",
"     figure 1",
"    </a>",
"    ). The following radiographs demonstrate the value of CT for detecting possible malignant lymph nodes:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Malignant infiltration of ipsilateral hilar lymph nodes defines N1 disease (",
"      <a class=\"graphic graphic_diagnosticimage graphicRef77415 \" href=\"UTD.htm?4/10/4271\">",
"       image 10",
"      </a>",
"      )",
"     </li>",
"     <li>",
"      Malignant infiltration of ipsilateral mediastinal",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      subcarinal lymph nodes defines N2 disease (",
"      <a class=\"graphic graphic_diagnosticimage graphicRef50988 \" href=\"UTD.htm?10/21/10591\">",
"       image 11",
"      </a>",
"      )",
"     </li>",
"     <li>",
"      Malignant infiltration of contralateral mediastinal, contralateral hilar, supraclavicular, or scalene lymph nodes defines N3 disease (",
"      <a class=\"graphic graphic_diagnosticimage graphicRef51659 \" href=\"UTD.htm?26/38/27233\">",
"       image 12",
"      </a>",
"      and",
"      <a class=\"graphic graphic_diagnosticimage graphicRef65827 \" href=\"UTD.htm?11/54/12129\">",
"       image 13",
"      </a>",
"      and",
"      <a class=\"graphic graphic_diagnosticimage graphicRef50958 \" href=\"UTD.htm?25/27/26047\">",
"       image 14",
"      </a>",
"      and",
"      <a class=\"graphic graphic_diagnosticimage graphicRef73208 \" href=\"UTD.htm?24/49/25375\">",
"       image 15",
"      </a>",
"      and",
"      <a class=\"graphic graphic_diagnosticimage graphicRef59386 \" href=\"UTD.htm?1/7/1151\">",
"       image 16",
"      </a>",
"      )",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h3\">",
"     Metastases",
"    </span>",
"    &nbsp;&mdash;&nbsp;CT of the chest may identify pleural nodules, a pleural effusion, a pericardial effusion, or separate parenchymal tumor nodule(s) in the contralateral lung. These abnormalities define M1a disease if they are due to metastatic NSCLC (",
"    <a class=\"graphic graphic_table graphicRef80099 \" href=\"UTD.htm?36/41/37533\">",
"     table 1",
"    </a>",
"    ). CT of the brain or abdomen may detect focal lesions in the brain, liver, or adrenal gland. These abnormalities define M1b disease if they are due to metastatic NSCLC (",
"    <a class=\"graphic graphic_diagnosticimage graphicRef51255 \" href=\"UTD.htm?34/23/35186\">",
"     image 17",
"    </a>",
"    and",
"    <a class=\"graphic graphic_diagnosticimage graphicRef52467 \" href=\"UTD.htm?19/12/19663\">",
"     image 18",
"    </a>",
"    ). CT alone is insufficient to exclude bone metastases, although it may detect lytic or sclerotic bone metastases.",
"   </p>",
"   <p>",
"    Assignment of M1a or M1b disease on the basis of abnormalities detected by CT should be considered tentative. Contrast-enhanced CT of the brain detects brain metastases with a sensitivity and specificity of 76 and 82 percent, respectively, in a population with a prevalence of 14 percent [",
"    <a class=\"abstract\" href=\"UTD.htm?19/10/19625/abstract/25\">",
"     25",
"    </a>",
"    ]. The accuracy of CT of the abdomen in detecting liver or adrenal metastases is uncertain due to widely variable estimates. Thus, tissue sampling is required to confirm that lesions are due to metastatic disease. This is reviewed elsewhere. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?14/31/14841?source=see_link&amp;anchor=H5#H5\">",
"     \"Diagnosis and staging of non-small cell lung cancer\", section on 'Tissue sampling'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?14/31/14841?source=see_link&amp;anchor=H11#H11\">",
"     \"Diagnosis and staging of non-small cell lung cancer\", section on 'Approach to diagnosis and staging'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?14/31/14841?source=see_link&amp;anchor=H10#H10\">",
"     \"Diagnosis and staging of non-small cell lung cancer\", section on 'Staging'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h2\">",
"     Positron emission tomography",
"    </span>",
"    &nbsp;&mdash;&nbsp;PET is unique in that it provides metabolic rather than anatomic information. In other words, it distinguishes structures on the basis of metabolic activity.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h3\">",
"     Technique",
"    </span>",
"    &nbsp;&mdash;&nbsp;PET begins with the intravenous injection of a radionuclide bound to an analog of D-glucose (18-fluoro-2-deoxyglucose [FDG]). While all cells will take up some of the FDG for glycolysis, cells with increased metabolic activity (eg, NSCLC) and cancer cells with aerobic glycolysis, will accumulate more FDG due to upregulation of glycolysis (ie, the Warburg effect). When the patient is imaged, two 0.511 MeV photons emitted by the FDG are detected. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?27/28/28102?source=see_link&amp;anchor=H2#H2\">",
"     \"Thoracic positron emission tomography\", section on 'Technical issues'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Axial, coronal, and sagittal projections of the image can be viewed. Cells with increased metabolic activity appear brighter than the surrounding tissues because they take up more FDG. Ultimately, the FDG is extruded from the cell, filtered by the renal glomeruli, and excreted in the urine.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h3\">",
"     Tumor",
"    </span>",
"    &nbsp;&mdash;&nbsp;PET does not provide sufficient detail to help determine whether a tumor is T1a, T1b, T2a, T2b, T3, or T4 (",
"    <a class=\"graphic graphic_table graphicRef80099 \" href=\"UTD.htm?36/41/37533\">",
"     table 1",
"    </a>",
"    ). However, it does distinguish malignant lesions (increased uptake) from benign lesions (normal or decreased uptake) more accurately than CT (",
"    <a class=\"graphic graphic_picture graphicRef53272 \" href=\"UTD.htm?6/46/6894\">",
"     picture 2",
"    </a>",
"    and",
"    <a class=\"graphic graphic_diagnosticimage graphicRef65082 \" href=\"UTD.htm?43/47/44799\">",
"     image 19",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"UTD.htm?19/10/19625/abstract/27\">",
"     27",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?16/43/17080?source=see_link&amp;anchor=H11#H11\">",
"     \"Computed tomographic and positron emission tomographic scanning of pulmonary nodules\", section on 'Positron emission tomography (PET)'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13\">",
"    <span class=\"h3\">",
"     Lymph nodes",
"    </span>",
"    &nbsp;&mdash;&nbsp;PET can detect malignant disease in lymph nodes of normal size, thus overcoming one of the major limitations of CT (",
"    <a class=\"graphic graphic_diagnosticimage graphicRef61004 \" href=\"UTD.htm?42/36/43598\">",
"     image 20",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"UTD.htm?19/10/19625/abstract/28\">",
"     28",
"    </a>",
"    ]. This is the reason why PET is more sensitive than CT for detecting lymph node metastases [",
"    <a class=\"abstract\" href=\"UTD.htm?19/10/19625/abstract/27,29-33\">",
"     27,29-33",
"    </a>",
"    ]. However, PET is also more specific. This was illustrated by a study that found that PET differentiated N0 or N1 disease from N2 or N3 disease with a sensitivity and specificity of 89 and 92 percent, respectively (",
"    <a class=\"graphic graphic_table graphicRef80099 \" href=\"UTD.htm?36/41/37533\">",
"     table 1",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"UTD.htm?19/10/19625/abstract/27\">",
"     27",
"    </a>",
"    ]. The sensitivity and specificity of CT were 65 and 80 percent, respectively.",
"   </p>",
"   <p>",
"    PET has a good negative predictive value, but poor positive predictive value [",
"    <a class=\"abstract\" href=\"UTD.htm?19/10/19625/abstract/27\">",
"     27",
"    </a>",
"    ]. This means that false positive results are relatively common with PET, which could lead to the assignment of an incorrectly high stage of disease and a missed opportunity for surgical cure. Thus, a positive PET should NOT be considered proof of lymph node metastasis. Tissue sampling is required to confirm the presence or absence of regional lymph node involvement. This is discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?14/31/14841?source=see_link&amp;anchor=H5#H5\">",
"     \"Diagnosis and staging of non-small cell lung cancer\", section on 'Tissue sampling'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?14/31/14841?source=see_link&amp;anchor=H11#H11\">",
"     \"Diagnosis and staging of non-small cell lung cancer\", section on 'Approach to diagnosis and staging'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H14\">",
"    <span class=\"h3\">",
"     Metastases",
"    </span>",
"    &nbsp;&mdash;&nbsp;Whole body PET detects metastatic NSCLC nearly anywhere in the body with greater sensitivity than CT [",
"    <a class=\"abstract\" href=\"UTD.htm?19/10/19625/abstract/19,34,35\">",
"     19,34,35",
"    </a>",
"    ]. Two exceptions have to be considered:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      PET is not suitable for the detection of brain metastases because of the high glucose uptake of normal surrounding brain tissue. Patients who undergo whole body PET require dedicated brain imaging, generally contrast-enhanced CT or MRI.",
"     </li>",
"     <li>",
"      It is unclear whether PET is superior to CT for detection of liver metastases. Some series suggest that PET may be superior to CT in patients with NSCLC metastases to the liver [",
"      <a class=\"abstract\" href=\"UTD.htm?19/10/19625/abstract/36,37\">",
"       36,37",
"      </a>",
"      ], but not in patients with other types of malignancy [",
"      <a class=\"abstract\" href=\"UTD.htm?19/10/19625/abstract/38,39\">",
"       38,39",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    The impact of detecting an extrathoracic abnormality was illustrated by a prospective study of 109 patients with NSCLC [",
"    <a class=\"abstract\" href=\"UTD.htm?19/10/19625/abstract/34\">",
"     34",
"    </a>",
"    ]. Whole body PET led to a change in the M designation (ie, M0, M1a, M1b) in 14 percent of the patients (",
"    <a class=\"graphic graphic_table graphicRef80099 \" href=\"UTD.htm?36/41/37533\">",
"     table 1",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"UTD.htm?19/10/19625/abstract/34\">",
"     34",
"    </a>",
"    ]. Most other studies have found an even higher rate of altered patient management (25 to 50 percent) among patients who underwent PET, usually due to the detection of distant metastases [",
"    <a class=\"abstract\" href=\"UTD.htm?19/10/19625/abstract/29,30,34,40-42\">",
"     29,30,34,40-42",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Identification of presumed metastatic disease on the basis of PET should be considered tentative. Tissue sampling is required to confirm that such lesions are due to metastatic disease. This is discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?14/31/14841?source=see_link&amp;anchor=H5#H5\">",
"     \"Diagnosis and staging of non-small cell lung cancer\", section on 'Tissue sampling'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?14/31/14841?source=see_link&amp;anchor=H11#H11\">",
"     \"Diagnosis and staging of non-small cell lung cancer\", section on 'Approach to diagnosis and staging'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H15\">",
"    <span class=\"h2\">",
"     Integrated PET/CT",
"    </span>",
"    &nbsp;&mdash;&nbsp;Integrated",
"    <span class=\"nowrap\">",
"     PET/CT",
"    </span>",
"    is a modality that combines PET and CT, thus providing overlapping anatomic and metabolic information. The technical aspects of integrated",
"    <span class=\"nowrap\">",
"     PET/CT",
"    </span>",
"    are the same as those of CT and PET, as described above.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H16\">",
"    <span class=\"h3\">",
"     Tumor",
"    </span>",
"    &nbsp;&mdash;&nbsp;Integrated",
"    <span class=\"nowrap\">",
"     PET/CT",
"    </span>",
"    provides the anatomic detail that is necessary to designate the primary tumor as T1a, T1b, T2a, T2b, T3, or T4 (",
"    <a class=\"graphic graphic_table graphicRef80099 \" href=\"UTD.htm?36/41/37533\">",
"     table 1",
"    </a>",
"    ). It also distinguishes malignant lesions (increased uptake) from benign lesions (normal or decreased uptake) more accurately than either CT or PET alone [",
"    <a class=\"abstract\" href=\"UTD.htm?19/10/19625/abstract/43,44\">",
"     43,44",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H17\">",
"    <span class=\"h3\">",
"     Lymph nodes",
"    </span>",
"    &nbsp;&mdash;&nbsp;Integrated",
"    <span class=\"nowrap\">",
"     PET/CT",
"    </span>",
"    has a good negative predictive value and a poor positive predictive value [",
"    <a class=\"abstract\" href=\"UTD.htm?19/10/19625/abstract/19,45-49\">",
"     19,45-49",
"    </a>",
"    ]. This suggests that false positive results are common with integrated",
"    <span class=\"nowrap\">",
"     PET/CT,",
"    </span>",
"    which could lead to the assignment of an incorrectly high stage of disease and a missed opportunity for surgical cure. As a result, a positive integrated",
"    <span class=\"nowrap\">",
"     PET/CT",
"    </span>",
"    should NOT be considered proof of lymph node metastasis. Tissue sampling is required to confirm the presence or absence of regional lymph node involvement, which is discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?14/31/14841?source=see_link&amp;anchor=H5#H5\">",
"     \"Diagnosis and staging of non-small cell lung cancer\", section on 'Tissue sampling'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?14/31/14841?source=see_link&amp;anchor=H11#H11\">",
"     \"Diagnosis and staging of non-small cell lung cancer\", section on 'Approach to diagnosis and staging'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The test characteristics of integrated",
"    <span class=\"nowrap\">",
"     PET/CT",
"    </span>",
"    were determined by an observational study in which 132 patients with potentially resectable NSCLC underwent PET and contrast-enhanced CT, followed by mediastinoscopy [",
"    <a class=\"abstract\" href=\"UTD.htm?19/10/19625/abstract/45\">",
"     45",
"    </a>",
"    ]. The sensitivity of CT plus PET, CT alone, and PET alone for the detection of lymph node metastases was 98, 86, and 94 percent, respectively. Specificity was 44, 67, and 59 percent, respectively. The negative predictive value of CT plus PET was 98 percent.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H18\">",
"    <span class=\"h3\">",
"     Metastases",
"    </span>",
"    &nbsp;&mdash;&nbsp;Integrated",
"    <span class=\"nowrap\">",
"     PET/CT",
"    </span>",
"    may be better than PET or CT alone in detecting extrathoracic metastases. This was demonstrated by a retrospective study of 217 patients with lung cancer (mostly NSCLC) who underwent integrated",
"    <span class=\"nowrap\">",
"     PET/CT",
"    </span>",
"    [",
"    <a class=\"abstract\" href=\"UTD.htm?19/10/19625/abstract/50\">",
"     50",
"    </a>",
"    ]. Malignant extrathoracic lesions were identified in 41 patients (19 percent). The sensitivity, specificity, positive predictive value, and negative predictive value of integrated",
"    <span class=\"nowrap\">",
"     PET/CT",
"    </span>",
"    for detecting malignant extrathoracic lesions was 98, 92, 89, and 98 percent, respectively. These values were better than those obtained by PET alone (98, 22, 75, and 89, respectively) or CT alone (98, 18, 71, and 89, respectively).",
"   </p>",
"   <p>",
"    While integrated",
"    <span class=\"nowrap\">",
"     PET/CT",
"    </span>",
"    is clearly superior to CT or PET alone at identifying distant metastases, caution is warranted when a solitary extrapulmonary lesion is identified by integrated",
"    <span class=\"nowrap\">",
"     PET/CT",
"    </span>",
"    because false positive results are common. In a study of 350 patients, presumed solitary metastases were identified in 72 patients (20 percent) [",
"    <a class=\"abstract\" href=\"UTD.htm?19/10/19625/abstract/51\">",
"     51",
"    </a>",
"    ]. However, further evaluation revealed that the lesions were not metastatic in 32 patients (46 percent).",
"   </p>",
"   <p>",
"    Given the frequency of false positive results, integrated",
"    <span class=\"nowrap\">",
"     PET/CT",
"    </span>",
"    that is positive for a possible metastatic lesion should NOT be considered proof of metastasis. Tissue sampling is required to confirm the presence or absence of metastatic disease, which is discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?14/31/14841?source=see_link&amp;anchor=H5#H5\">",
"     \"Diagnosis and staging of non-small cell lung cancer\", section on 'Tissue sampling'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?14/31/14841?source=see_link&amp;anchor=H11#H11\">",
"     \"Diagnosis and staging of non-small cell lung cancer\", section on 'Approach to diagnosis and staging'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H19\">",
"    <span class=\"h3\">",
"     Overall impact",
"    </span>",
"    &nbsp;&mdash;&nbsp;The impact of integrated",
"    <span class=\"nowrap\">",
"     PET/CT",
"    </span>",
"    on staging and therapy was illustrated by a trial that randomly assigned 189 patients with newly diagnosed or suspected NSCLC to undergo either conventional staging plus integrated",
"    <span class=\"nowrap\">",
"     PET/CT",
"    </span>",
"    or conventional staging alone [",
"    <a class=\"abstract\" href=\"UTD.htm?19/10/19625/abstract/52\">",
"     52",
"    </a>",
"    ]. Patients who underwent conventional staging plus integrated",
"    <span class=\"nowrap\">",
"     PET/CT",
"    </span>",
"    were less likely to be offered surgical therapy. Among those in the conventional staging plus integrated",
"    <span class=\"nowrap\">",
"     PET/CT",
"    </span>",
"    group who were not offered surgery, approximately one-third had been deemed unresectable on the basis of the integrated",
"    <span class=\"nowrap\">",
"     PET/CT",
"    </span>",
"    results. In addition, thoracotomy was less likely to be futile among those who received conventional staging plus integrated",
"    <span class=\"nowrap\">",
"     PET/CT",
"    </span>",
"    (35 versus 58 percent). A thoracotomy was called futile if the lesion was benign; the patient died within 12 months; there was unresectable T3 or T4 disease, N2 disease, stage IIIB or IV disease; or, tumor recurrence occurred within 12 months.",
"   </p>",
"   <p>",
"    While it is desirable to correctly increase a patient's clinical-diagnostic stage and potentially spare the patient unnecessary surgery, evidence is available from a randomized trial that integrated",
"    <span class=\"nowrap\">",
"     PET/CT",
"    </span>",
"    can incorrectly increase a patient's clinical-diagnostic stage [",
"    <a class=\"abstract\" href=\"UTD.htm?19/10/19625/abstract/53\">",
"     53",
"    </a>",
"    ]. This could lead to surgical therapy being inappropriately withheld from some patients. The clinical-diagnostic stage is correctly upstaged approximately three times more frequently than it is incorrectly upstaged.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H20\">",
"    <span class=\"h2\">",
"     Magnetic resonance imaging",
"    </span>",
"    &nbsp;&mdash;&nbsp;The role of magnetic resonance imaging (MRI) in the diagnosis and staging of NSCLC is more limited than the role of CT. However, MRI may be helpful when brain metastasis, adrenal metastasis, mediastinal invasion, chest wall invasion, or spinal cord invasion is suspected.",
"   </p>",
"   <p>",
"    Imaging the brain with Gadolinium-based contrast material enhanced MRI is preferable, although contrast-enhanced CT is a reasonable alternative if MRI is not available. MRI offers several advantages:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Contrast-enhanced MRI detects brain lesions and differentiates metastases from other central nervous system lesions with greater sensitivity than nonenhanced MRI, contrast-enhanced CT, or nonenhanced CT [",
"      <a class=\"abstract\" href=\"UTD.htm?19/10/19625/abstract/25,54\">",
"       25,54",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Contrast-enhanced MRI uses a paramagnetic contrast agent (gadolinium), rather than an iodinated contrast agent. The paramagnetic agent tends to be better tolerated and can be used in many patients who have contraindications to iodinated contrast material, provided they have normal renal function. However, gadolinium-based contrast agents should be avoided in patients with renal failure due to the risk of inducing nephrogenic systemic fibrosis [",
"      <a class=\"abstract\" href=\"UTD.htm?19/10/19625/abstract/55\">",
"       55",
"      </a>",
"      ]. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?30/22/31082?source=see_link&amp;anchor=H4#H4\">",
"       \"Nephrogenic systemic fibrosis/nephrogenic fibrosing dermopathy in advanced renal failure\", section on 'Gadolinium'",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    MRI may also be helpful in distinguishing benign, fat-containing adrenal adenomas from adrenal metastases. Adrenal adenomas have low signal intensity on out-of-phase gradient echo MRI due to their intracellular fat content [",
"    <a class=\"abstract\" href=\"UTD.htm?19/10/19625/abstract/56,57\">",
"     56,57",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The technical aspects of MRI are described separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?3/52/3910?source=see_link\">",
"     \"Magnetic resonance imaging of the thorax\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H21\">",
"    <span class=\"h2\">",
"     Bone scan",
"    </span>",
"    &nbsp;&mdash;&nbsp;Imaging of the skeleton is indicated in patients who have symptoms (eg, focal bone pain), signs (eg, difficulty weight bearing), or laboratory abnormalities (eg, elevated alkaline phosphatase with normal gammaglutamyl transpeptidase) that raise the suspicion for bone metastases [",
"    <a class=\"abstract\" href=\"UTD.htm?19/10/19625/abstract/14,30,58,59\">",
"     14,30,58,59",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Bone metastases can be identified with a technetium 99m MDP nuclear medicine scan. Such bone scans were once common, but they have been largely displaced by PET for two major reasons. First, PET detects bone metastases with similar sensitivity and better specificity than bone scans [",
"    <a class=\"abstract\" href=\"UTD.htm?19/10/19625/abstract/37,60\">",
"     37,60",
"    </a>",
"    ]. Second, PET has the added advantage of being able to identify metastases in visceral organs.",
"   </p>",
"   <p>",
"    Advantages of bone scans include that they are less time-consuming and less likely to have false negative results from osteoblastic lesions, compared to PET. According to a meta-analysis of eight studies (723 patients), bone scans identified bone metastases with a sensitivity, specificity, positive predictive value, and negative predictive value of 82, 62, 32, and 90 percent, respectively, in a population with a prevalence of 20 percent [",
"    <a class=\"abstract\" href=\"UTD.htm?19/10/19625/abstract/25\">",
"     25",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H22\">",
"    <span class=\"h1\">",
"     GENERAL APPROACH TO IMAGING",
"    </span>",
"    &nbsp;&mdash;&nbsp;This section describes our approach to imaging patients with suspected non-small cell lung cancer (NSCLC). It is a key part of the diagnostic and staging evaluation, which is described separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?14/31/14841?source=see_link\">",
"     \"Diagnosis and staging of non-small cell lung cancer\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Chest radiography is the initial imaging modality for evaluating a patient with suspected non-small cell lung cancer (NSCLC). The current chest radiograph should be compared to prior chest radiographs, if available, in order to determine if the lesion is new, enlarging, or stable.",
"   </p>",
"   <p>",
"    All patients should undergo computed tomography (CT) of the chest, except those whose lesion has been stable for longer than two years. CT alone is usually sufficient to designate the tumor as T1a, T1b, T2a, T2b, T3, or T4 (",
"    <a class=\"graphic graphic_table graphicRef80099 \" href=\"UTD.htm?36/41/37533\">",
"     table 1",
"    </a>",
"    ). Additional imaging studies are infrequently necessary for tumor characterization, but may include magnetic resonance imaging (MRI) to identify invasion of the spine or brachial plexus, positron emission tomography (PET) to distinguish tumor from peritumoral atelectasis, or transesophageal echocardiography to detect mediastinal or vascular invasion.",
"   </p>",
"   <p>",
"    Whole body PET should be performed next in most patients with suspected NSCLC. Exceptions are patients whose CT of the chest revealed possible M1a disease (malignant pleural nodules, malignant pleural effusion, malignant pericardial effusion) or M1b disease (liver metastasis, adrenal metastasis) (",
"    <a class=\"graphic graphic_table graphicRef80099 \" href=\"UTD.htm?36/41/37533\">",
"     table 1",
"    </a>",
"    ). Such patients may proceed directly to tissue sampling to confirm the diagnosis of stage IV NSCLC, since new findings on PET will not change the disease stage.",
"   </p>",
"   <p>",
"    The purpose of whole body PET is to provide additional evidence that the primary tumor is malignant, identify potential lymph node metastases (N1, N2, or N3 disease), and detect possible intrathoracic (M1a disease) or distant metastases (M1b disease) (",
"    <a class=\"graphic graphic_table graphicRef80099 \" href=\"UTD.htm?36/41/37533\">",
"     table 1",
"    </a>",
"    ). Suspicious lesions should be sampled since PET has a high false-positive rate, which could lead to incorrect upstaging and a missed opportunity for surgical cure. The sampling target should be the lesion that will establish the highest disease stage, assuming that the lesion is accessible and the procedure risk is low. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?14/31/14841?source=see_link&amp;anchor=H5#H5\">",
"     \"Diagnosis and staging of non-small cell lung cancer\", section on 'Tissue sampling'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?14/31/14841?source=see_link&amp;anchor=H11#H11\">",
"     \"Diagnosis and staging of non-small cell lung cancer\", section on 'Approach to diagnosis and staging'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Integrated",
"    <span class=\"nowrap\">",
"     PET/CT",
"    </span>",
"    is an acceptable alternative to performing an initial CT of the chest followed by whole body PET.",
"   </p>",
"   <p>",
"    Patients whose CT of the chest (including the liver and adrenal glands) and either whole body PET or integrated",
"    <span class=\"nowrap\">",
"     PET/CT",
"    </span>",
"    do not indicate potential lymph node metastases, intrathoracic metastases, or distant metastases do not require additional imaging. This reflects the low rate of false negative results among both whole body PET and integrated",
"    <span class=\"nowrap\">",
"     PET/CT.",
"    </span>",
"    Such patients can be tentatively staged as having N0M0 disease. Some patients will still undergo tissue sampling to confirm the diagnosis of NSCLC, while others may be considered for surgical therapy without further imaging or tissue sampling. Surgical therapy without prior tissue sampling is discussed elsewhere. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?14/31/14841?source=see_link&amp;anchor=H11#H11\">",
"     \"Diagnosis and staging of non-small cell lung cancer\", section on 'Approach to diagnosis and staging'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Imaging the brain is indicated in all patients with neurologic symptoms or signs, since brain metastases are likely to be undetected by the other imaging modalities. Patients without neurologic abnormalities do not require dedicated imaging of the brain unless there are other reasons to suspect brain metastases, such as extensive local disease, regional lymph node involvement, or other distant metastases. Contrast-enhanced MRI is the preferred method of imaging the brain because of its higher sensitivity, but contrast-enhanced CT is a reasonable alternative if MRI is not available. Patients who undergo an initial contrast-enhanced CT should proceed to contrast-enhanced MRI if the contrast-enhanced CT is negative and a high clinical suspicion for brain metastases persists.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H23\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Imaging is a key component of the diagnosis and staging of suspected non-small cell lung cancer (NSCLC). (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?14/31/14841?source=see_link\">",
"       \"Diagnosis and staging of non-small cell lung cancer\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Computed tomography (CT) of the chest should be performed in all patients with suspected NSCLC. It characterizes the size of the tumor and its relationship to adjacent structures. CT may also identify potential lymph node or distant metastases. (See",
"      <a class=\"local\" href=\"#H5\">",
"       'Computed tomography'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H22\">",
"       'General approach to imaging'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Whole body positron emission tomography (PET) should be performed next in most patients. PET provides additional evidence that the primary tumor is malignant, identifies potential lymph node metastases, and detects possible intrathoracic or distant metastases. (See",
"      <a class=\"local\" href=\"#H10\">",
"       'Positron emission tomography'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H22\">",
"       'General approach to imaging'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Integrated",
"      <span class=\"nowrap\">",
"       PET/CT,",
"      </span>",
"      if available, is preferred over an initial CT of the chest followed by whole body PET. (See",
"      <a class=\"local\" href=\"#H15\">",
"       'Integrated PET/CT'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H22\">",
"       'General approach to imaging'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Possible metastatic lesions should be sampled. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?14/31/14841?source=see_link&amp;anchor=H11#H11\">",
"       \"Diagnosis and staging of non-small cell lung cancer\", section on 'Approach to diagnosis and staging'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      No additional imaging is required for patients whose CT and either PET or integrated",
"      <span class=\"nowrap\">",
"       PET/CT",
"      </span>",
"      did not indicate potential lymph node metastases, intrathoracic metastases, or distant metastases. (See",
"      <a class=\"local\" href=\"#H22\">",
"       'General approach to imaging'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Imaging the brain is indicated in all patients with neurologic symptoms or signs. Contrast-enhanced MRI is the preferred method. (See",
"      <a class=\"local\" href=\"#H20\">",
"       'Magnetic resonance imaging'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H22\">",
"       'General approach to imaging'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/10/19625/abstract/1\">",
"      Munden RF, Swisher SS, Stevens CW, Stewart DJ. Imaging of the patient with non-small cell lung cancer. Radiology 2005; 237:803.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/10/19625/abstract/2\">",
"      Goldstraw P, Crowley J, Chansky K, et al. The IASLC Lung Cancer Staging Project: proposals for the revision of the TNM stage groupings in the forthcoming (seventh) edition of the TNM Classification of malignant tumours. J Thorac Oncol 2007; 2:706.",
"     </a>",
"    </li>",
"    <li>",
"     AJCC Cancer Staging Manual, 6th ed, Greene FL, Page DL, Fleming ID, et al (Eds), Springer-Verlag, New York 2002. p.435.",
"    </li>",
"    <li>",
"     UICC TNM Classification of Malignant Tumors, 6th Ed, Sobin L, Wittekind C (Eds), Wiley-Liss, New York 2002. p.272.",
"    </li>",
"    <li>",
"     Goldstraw P. Edition of TNM for Lung and Pleural Tumours. In: IASLC Staging Manual in Thoracic Oncology, Editorial Rx Press, Orange Park, FL 2009. p.56.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/10/19625/abstract/6\">",
"      Verschakelen JA, De Wever W, Bogaert J. Role of computed tomography in lung cancer staging. Curr Opin Pulm Med 2004; 10:248.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/10/19625/abstract/7\">",
"      Primack SL, Lee KS, Logan PM, et al. Bronchogenic carcinoma: utility of CT in the evaluation of patients with suspected lesions. Radiology 1994; 193:795.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/10/19625/abstract/8\">",
"      Quint LE, Francis IR, Wahl RL, et al. Preoperative staging of non-small-cell carcinoma of the lung: imaging methods. AJR Am J Roentgenol 1995; 164:1349.",
"     </a>",
"    </li>",
"    <li>",
"     Webb WR. Lung cancer staging: The role of imaging. In: Lung Cancer, Johnson BE, Johnson DH (Eds), Wiley-Liss, New York 1995. p.97.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/10/19625/abstract/10\">",
"      McLoud TC, Bourgouin PM, Greenberg RW, et al. Bronchogenic carcinoma: analysis of staging in the mediastinum with CT by correlative lymph node mapping and sampling. Radiology 1992; 182:319.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/10/19625/abstract/11\">",
"      Webb WR, Gatsonis C, Zerhouni EA, et al. CT and MR imaging in staging non-small cell bronchogenic carcinoma: report of the Radiologic Diagnostic Oncology Group. Radiology 1991; 178:705.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/10/19625/abstract/12\">",
"      Nickoloff EL, Lu ZF, Dutta AK, So JC. Radiation dose descriptors: BERT, COD, DAP, and other strange creatures. Radiographics 2008; 28:1439.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/10/19625/abstract/13\">",
"      Wall BF, Hart D. Revised radiation doses for typical X-ray examinations. Report on a recent review of doses to patients from medical X-ray examinations in the UK by NRPB. National Radiological Protection Board. Br J Radiol 1997; 70:437.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/10/19625/abstract/14\">",
"      Pretreatment evaluation of non-small-cell lung cancer. The American Thoracic Society and The European Respiratory Society. Am J Respir Crit Care Med 1997; 156:320.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/10/19625/abstract/15\">",
"      Parry RA, Glaze SA, Archer BR. The AAPM/RSNA physics tutorial for residents. Typical patient radiation doses in diagnostic radiology. Radiographics 1999; 19:1289.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/10/19625/abstract/16\">",
"      Hendee WR, O'Connor MK. Radiation risks of medical imaging: separating fact from fantasy. Radiology 2012; 264:312.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/10/19625/abstract/17\">",
"      Amis ES Jr, Butler PF, Applegate KE, et al. American College of Radiology white paper on radiation dose in medicine. J Am Coll Radiol 2007; 4:272.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/10/19625/abstract/18\">",
"      Mayo JR, Aldrich J, Muller NL, Fleischner Society. Radiation exposure at chest CT: a statement of the Fleischner Society. Radiology 2003; 228:15.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/10/19625/abstract/19\">",
"      G&aacute;mez C, Rosell R, Fern&aacute;ndez A, et al. PET/CT fusion scan in lung cancer: current recommendations and innovations. J Thorac Oncol 2006; 1:74.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/10/19625/abstract/20\">",
"      Iezzi A, Magarelli N, Carriero A, et al. [Staging of pulmonary apex tumors. Computerized tomography versus magnetic resonance]. Radiol Med 1994; 88:24.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/10/19625/abstract/21\">",
"      Mayo JR. Magnetic resonance imaging of the chest. Where we stand. Radiol Clin North Am 1994; 32:795.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/10/19625/abstract/22\">",
"      Laissy JP, Soyer P, Sekkal SR, et al. Assessment of vascular involvement with magnetic resonance angiography (MRA) in Pancoast syndrome. Magn Reson Imaging 1995; 13:523.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/10/19625/abstract/23\">",
"      Touliopoulos P, Costello P. Helical (spiral) CT of the thorax. Radiol Clin North Am 1995; 33:843.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/10/19625/abstract/24\">",
"      Schr&ouml;der C, Sch&ouml;nhofer B, Vogel B. Transesophageal echographic determination of aortic invasion by lung cancer. Chest 2005; 127:438.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/10/19625/abstract/25\">",
"      Silvestri GA, Gould MK, Margolis ML, et al. Noninvasive staging of non-small cell lung cancer: ACCP evidenced-based clinical practice guidelines (2nd edition). Chest 2007; 132:178S.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/10/19625/abstract/26\">",
"      Walker CM, Chung JH, Abbott GF, et al. Mediastinal lymph node staging: from noninvasive to surgical. AJR Am J Roentgenol 2012; 199:W54.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/10/19625/abstract/27\">",
"      Vansteenkiste JF, Stroobants SS. PET scan in lung cancer: current recommendations and innovation. J Thorac Oncol 2006; 1:71.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/10/19625/abstract/28\">",
"      Patz EF Jr, Lowe VJ, Goodman PC, Herndon J. Thoracic nodal staging with PET imaging with 18FDG in patients with bronchogenic carcinoma. Chest 1995; 108:1617.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/10/19625/abstract/29\">",
"      Pieterman RM, van Putten JW, Meuzelaar JJ, et al. Preoperative staging of non-small-cell lung cancer with positron-emission tomography. N Engl J Med 2000; 343:254.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/10/19625/abstract/30\">",
"      van Tinteren H, Hoekstra OS, Smit EF, et al. Effectiveness of positron emission tomography in the preoperative assessment of patients with suspected non-small-cell lung cancer: the PLUS multicentre randomised trial. Lancet 2002; 359:1388.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/10/19625/abstract/31\">",
"      Gould MK, Kuschner WG, Rydzak CE, et al. Test performance of positron emission tomography and computed tomography for mediastinal staging in patients with non-small-cell lung cancer: a meta-analysis. Ann Intern Med 2003; 139:879.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/10/19625/abstract/32\">",
"      Fischer BM, Mortensen J, H&oslash;jgaard L. Positron emission tomography in the diagnosis and staging of lung cancer: a systematic, quantitative review. Lancet Oncol 2001; 2:659.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/10/19625/abstract/33\">",
"      Birim O, Kappetein AP, Stijnen T, Bogers AJ. Meta-analysis of positron emission tomographic and computed tomographic imaging in detecting mediastinal lymph node metastases in nonsmall cell lung cancer. Ann Thorac Surg 2005; 79:375.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/10/19625/abstract/34\">",
"      Bury T, Dowlati A, Paulus P, et al. Whole-body 18FDG positron emission tomography in the staging of non-small cell lung cancer. Eur Respir J 1997; 10:2529.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/10/19625/abstract/35\">",
"      Weder W, Schmid RA, Bruchhaus H, et al. Detection of extrathoracic metastases by positron emission tomography in lung cancer. Ann Thorac Surg 1998; 66:886.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/10/19625/abstract/36\">",
"      Valk PE, Pounds TR, Hopkins DM, et al. Staging non-small cell lung cancer by whole-body positron emission tomographic imaging. Ann Thorac Surg 1995; 60:1573.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/10/19625/abstract/37\">",
"      Marom EM, McAdams HP, Erasmus JJ, et al. Staging non-small cell lung cancer with whole-body PET. Radiology 1999; 212:803.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/10/19625/abstract/38\">",
"      Hustinx R, Paulus P, Jacquet N, et al. Clinical evaluation of whole-body 18F-fluorodeoxyglucose positron emission tomography in the detection of liver metastases. Ann Oncol 1998; 9:397.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/10/19625/abstract/39\">",
"      Delbeke D, Martin WH, Sandler MP, et al. Evaluation of benign vs malignant hepatic lesions with positron emission tomography. Arch Surg 1998; 133:510.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/10/19625/abstract/40\">",
"      Kalff V, Hicks RJ, MacManus MP, et al. Clinical impact of (18)F fluorodeoxyglucose positron emission tomography in patients with non-small-cell lung cancer: a prospective study. J Clin Oncol 2001; 19:111.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/10/19625/abstract/41\">",
"      Saunders CA, Dussek JE, O'Doherty MJ, Maisey MN. Evaluation of fluorine-18-fluorodeoxyglucose whole body positron emission tomography imaging in the staging of lung cancer. Ann Thorac Surg 1999; 67:790.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/10/19625/abstract/42\">",
"      Lewis P, Griffin S, Marsden P, et al. Whole-body 18F-fluorodeoxyglucose positron emission tomography in preoperative evaluation of lung cancer. Lancet 1994; 344:1265.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/10/19625/abstract/43\">",
"      Yi CA, Lee KS, Kim BT, et al. Tissue characterization of solitary pulmonary nodule: comparative study between helical dynamic CT and integrated PET/CT. J Nucl Med 2006; 47:443.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/10/19625/abstract/44\">",
"      Kim SK, Allen-Auerbach M, Goldin J, et al. Accuracy of PET/CT in characterization of solitary pulmonary lesions. J Nucl Med 2007; 48:214.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/10/19625/abstract/45\">",
"      Pozo-Rodr&iacute;guez F, Mart&iacute;n de Nicol&aacute;s JL, S&aacute;nchez-Nistal MA, et al. Accuracy of helical computed tomography and [18F] fluorodeoxyglucose positron emission tomography for identifying lymph node mediastinal metastases in potentially resectable non-small-cell lung cancer. J Clin Oncol 2005; 23:8348.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/10/19625/abstract/46\">",
"      Antoch G, Stattaus J, Nemat AT, et al. Non-small cell lung cancer: dual-modality PET/CT in preoperative staging. Radiology 2003; 229:526.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/10/19625/abstract/47\">",
"      Lardinois D, Weder W, Hany TF, et al. Staging of non-small-cell lung cancer with integrated positron-emission tomography and computed tomography. N Engl J Med 2003; 348:2500.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/10/19625/abstract/48\">",
"      Cerfolio RJ, Ojha B, Bryant AS, et al. The accuracy of integrated PET-CT compared with dedicated PET alone for the staging of patients with nonsmall cell lung cancer. Ann Thorac Surg 2004; 78:1017.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/10/19625/abstract/49\">",
"      Wu Y, Li P, Zhang H, et al. Diagnostic value of fluorine 18 fluorodeoxyglucose positron emission tomography/computed tomography for the detection of metastases in non-small-cell lung cancer patients. Int J Cancer 2013; 132:E37.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/10/19625/abstract/50\">",
"      De Wever W, Vankan Y, Stroobants S, Verschakelen J. Detection of extrapulmonary lesions with integrated PET/CT in the staging of lung cancer. Eur Respir J 2007; 29:995.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/10/19625/abstract/51\">",
"      Lardinois D, Weder W, Roudas M, et al. Etiology of solitary extrapulmonary positron emission tomography and computed tomography findings in patients with lung cancer. J Clin Oncol 2005; 23:6846.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/10/19625/abstract/52\">",
"      Fischer B, Lassen U, Mortensen J, et al. Preoperative staging of lung cancer with combined PET-CT. N Engl J Med 2009; 361:32.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/10/19625/abstract/53\">",
"      Maziak DE, Darling GE, Inculet RI, et al. Positron emission tomography in staging early lung cancer: a randomized trial. Ann Intern Med 2009; 151:221.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/10/19625/abstract/54\">",
"      Schellinger PD, Meinck HM, Thron A. Diagnostic accuracy of MRI compared to CCT in patients with brain metastases. J Neurooncol 1999; 44:275.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/10/19625/abstract/55\">",
"      Weinreb JC. Which study when? Is gadolinium-enhanced MR imaging safer than iodine-enhanced CT? Radiology 2008; 249:3.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/10/19625/abstract/56\">",
"      Reinig JW, Stutley JE, Leonhardt CM, et al. Differentiation of adrenal masses with MR imaging: comparison of techniques. Radiology 1994; 192:41.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/10/19625/abstract/57\">",
"      Reinig JW, Doppman JL, Dwyer AJ, et al. Adrenal masses differentiated by MR. Radiology 1986; 158:81.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/10/19625/abstract/58\">",
"      Pfister DG, Johnson DH, Azzoli CG, et al. American Society of Clinical Oncology treatment of unresectable non-small-cell lung cancer guideline: update 2003. J Clin Oncol 2004; 22:330.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/10/19625/abstract/59\">",
"      Ernst A, Silvestri GA, Johnstone D, American College of Chest Physicians. Interventional pulmonary procedures: Guidelines from the American College of Chest Physicians. Chest 2003; 123:1693.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/10/19625/abstract/60\">",
"      Bury T, Barreto A, Daenen F, et al. Fluorine-18 deoxyglucose positron emission tomography for the detection of bone metastases in patients with non-small cell lung cancer. Eur J Nucl Med 1998; 25:1244.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 4599 Version 7.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1004-122.72.76.133-9F69235DB9-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f19_10_19625=[""].join("\n");
var outline_f19_10_19625=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H23\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      TNM STAGING",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      IMAGING MODALITIES",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      Chest radiography",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      Computed tomography",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      - Technique",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      - Tumor",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      - Lymph nodes",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      - Metastases",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      Positron emission tomography",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      - Technique",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      - Tumor",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H13\">",
"      - Lymph nodes",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H14\">",
"      - Metastases",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H15\">",
"      Integrated PET/CT",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H16\">",
"      - Tumor",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H17\">",
"      - Lymph nodes",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H18\">",
"      - Metastases",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H19\">",
"      - Overall impact",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H20\">",
"      Magnetic resonance imaging",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H21\">",
"      Bone scan",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H22\">",
"      GENERAL APPROACH TO IMAGING",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H23\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"PULM/4599\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"PULM/4599|DiagnosticImage\">",
"      <a href=\"#\" title=\"DIAGNOSTIC IMAGES\">",
"       DIAGNOSTIC IMAGES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"UTD.htm?13/11/13491\" title=\"diagnostic image 1\">",
"      Spiculated nodule CT",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"UTD.htm?40/37/41566\" title=\"diagnostic image 2\">",
"      Bronchioalveolar carcinoma CT",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"UTD.htm?31/11/31935\" title=\"diagnostic image 3\">",
"      Bronchogenic carcinoma CT",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"UTD.htm?37/41/38558\" title=\"diagnostic image 4\">",
"      Bronchogenic carcinoma CT I",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"UTD.htm?7/15/7423\" title=\"diagnostic image 5\">",
"      Bronchogenic carcinoma CT II",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"UTD.htm?28/16/28931\" title=\"diagnostic image 6\">",
"      Phrenic nerve invasion",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"UTD.htm?9/59/10175\" title=\"diagnostic image 7\">",
"      Mainstem bronchus mass CT",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"UTD.htm?39/43/40626\" title=\"diagnostic image 8\">",
"      Pulmonary vein invasion",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"UTD.htm?39/53/40799\" title=\"diagnostic image 9\">",
"      Bronchogenic carcinoma CT III",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"UTD.htm?4/10/4271\" title=\"diagnostic image 10\">",
"      Hilar lymph nodes CT I",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"UTD.htm?10/21/10591\" title=\"diagnostic image 11\">",
"      Paratracheal lymph node CT",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"UTD.htm?26/38/27233\" title=\"diagnostic image 12\">",
"      Lymph node enlargement CT",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"UTD.htm?11/54/12129\" title=\"diagnostic image 13\">",
"      Paratracheal lymph node CT I",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"UTD.htm?25/27/26047\" title=\"diagnostic image 14\">",
"      Prevascular adenopathy CT",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"UTD.htm?24/49/25375\" title=\"diagnostic image 15\">",
"      Bronchogenic carcinoma CT IV",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"UTD.htm?1/7/1151\" title=\"diagnostic image 16\">",
"      Tracheobronchial lymph nodes CT",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"UTD.htm?34/23/35186\" title=\"diagnostic image 17\">",
"      Bronchogenic carcinoma CT V",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"UTD.htm?19/12/19663\" title=\"diagnostic image 18\">",
"      Left adrenal metastasis CT",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"UTD.htm?43/47/44799\" title=\"diagnostic image 19\">",
"      FDG scan II",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"UTD.htm?42/36/43598\" title=\"diagnostic image 20\">",
"      Right lung tumor FDG scan",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"PULM/4599|FIG\">",
"      <a href=\"#\" title=\"FIGURES\">",
"       FIGURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?19/28/19914\" title=\"figure 1\">",
"      IASLC lymph node map",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"PULM/4599|PIC\">",
"      <a href=\"#\" title=\"PICTURES\">",
"       PICTURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?14/17/14609\" title=\"picture 1\">",
"      Squamous cell carcinoma MRI",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?6/46/6894\" title=\"picture 2\">",
"      FDG scan I",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"PULM/4599|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?36/41/37533\" title=\"table 1\">",
"      Lung cancer TMN staging 7th edition",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?19/43/20157\" title=\"table 2\">",
"      Lung cancer TMN staging 6th edition",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?13/4/13388\" title=\"table 3\">",
"      Changes 7th ed TNM lung ca",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?16/43/17080?source=related_link\">",
"      Computed tomographic and positron emission tomographic scanning of pulmonary nodules",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?14/31/14841?source=related_link\">",
"      Diagnosis and staging of non-small cell lung cancer",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?3/52/3910?source=related_link\">",
"      Magnetic resonance imaging of the thorax",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?30/22/31082?source=related_link\">",
"      Nephrogenic systemic fibrosis/nephrogenic fibrosing dermopathy in advanced renal failure",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?27/28/28102?source=related_link\">",
"      Thoracic positron emission tomography",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?43/21/44373?source=related_link\">",
"      Tumor node metastasis (TNM) staging system for non-small cell lung cancer",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f19_10_19626="Fibroid embolization 4b";
var content_f19_10_19626=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=OBGYN%2F63412%7EOBGYN%2F77132%7EOBGYN%2F56265%7EOBGYN%2F70070&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=OBGYN%2F63412%7EOBGYN%2F77132%7EOBGYN%2F56265%7EOBGYN%2F70070&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 501px\">",
"   <div class=\"ttl\">",
"    Left uterine angiogram",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 481px; height: 492px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Left uterine angiogram before uterine fibroid embolization demonstrates dilated branches of the left uterine artery supplying multiple hypervascular uterine fibroids (arrows) on the left.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Left uterine angiogram",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 420px; height: 275px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Left uterine angiogram after uterine artery embolization demonstrates successful occlusions of the left uterine artery and its branches (arrow).",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Right uterine angiogram",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 389px; height: 399px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Right uterine angiogram before uterine fibroid embolization demonstrates dilated branches of the right uterine artery supplying multiple hypervascular uterine fibroids (arrows) on the right.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Right uterine angiogram",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 388px; height: 400px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Right uterine angiogram after uterine fibroid embolization demonstrates successful occlusion of the right uterine artery and its branches (arrow). The patient's symptoms subsided after the procedure.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f19_10_19626=[""].join("\n");
var outline_f19_10_19626=null;
var title_f19_10_19627="Somatostatin physiology";
var content_f19_10_19627=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=GAST%2F67492&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=6\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=GAST%2F67492&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=6\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Somatostatin physiology",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tr>",
"      <td class=\"subtitle1_left\" rowspan=\"2\">",
"       CNS",
"      </td>",
"      <td>",
"       Inhibits growth release from pituitary",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Antinociception",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"subtitle1_left\" colspan=\"1\" rowspan=\"3\">",
"       Liver",
"      </td>",
"      <td>",
"       Decreases blood flow",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Inhibits bile duct secretion",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Inhibits gallbladder contraction",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"subtitle1_left\" colspan=\"1\" rowspan=\"2\">",
"       Pancreas",
"      </td>",
"      <td>",
"       Inhibits endocrine secretion",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Inhibits exocrine secretion",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"subtitle1_left\" colspan=\"1\" rowspan=\"7\">",
"       Gastrointestinal",
"      </td>",
"      <td>",
"       Inhibits salivary amylase release",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Inhibits gastric acid secretion and gastric emptying",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Inhibits gastrointestinal hormone secretion",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Slows gastrointestinal motility",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Inhibits absorption (primarily carbohydrates)",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Reduces intestinal fluid volume",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Decreases splanchnic blood flow",
"      </td>",
"     </tr>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"     CNS: central nervous system.",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f19_10_19627=[""].join("\n");
var outline_f19_10_19627=null;
var title_f19_10_19628="ACC AHA LV function CAD";
var content_f19_10_19628=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=CARD%2F63452&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=8\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=CARD%2F63452&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=8\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Recommendations for measurement of rest left ventricular (LV) function by echocardiography or radionuclide angiography in patients with chronic stable angina",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle2_single\">",
"        Class I",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        1. Echocardiography or radionuclide angiography (RNA) in patients with a history of prior myocardial infarction (MI), pathologic Q waves or symptoms or signs suggestive of heart failure (HF) to assess LV function.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        2. Echocardiography in patients with a systolic murmur suggesting mitral regurgitation to assess its severity and etiology.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        3. Echocardiography or RNA in patients with complex ventricular arrhythmias to assess LV function.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle2_single\">",
"        Class III",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        1. Routine periodic reassessment of stable patients for whom no new change in therapy is contemplated.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        2. Patients with a normal ECG, no history of MI and no symptoms or signs suggestive of HF.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle1_single\">",
"        ACC/AHA classification",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        <strong>",
"         Class I:",
"        </strong>",
"        Conditions for which there is evidence and/or general agreement that a given procedure or treatment is useful and effective.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1_start\">",
"        <strong>",
"         Class II:",
"        </strong>",
"        Conditions for which there is conflicting evidence and/or a divergence of opinion about the usefulness/efficacy of a procedure or treatment.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        <strong>",
"         Class IIa:",
"        </strong>",
"        Weight of evidence/opinion is in favor of usefulness/efficacy.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        <strong>",
"         Class IIb:",
"        </strong>",
"        Usefulness/efficacy less well established by evidence/opinion.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        <strong>",
"         Class III:",
"        </strong>",
"        Conditions for which there is evidence and/or general agreement that the procedure/treatment is not useful and in some cases may be harmful.",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Data from: Gibbons, RJ, Abrams, J, Chatterjee, K, et al. ACC/AHA 2002 guideline update for the management of patients with chronic stable angina--summary article: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on the Management of Patients With Chronic Stable Angina). Circulation 2003; 107:149.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f19_10_19628=[""].join("\n");
var outline_f19_10_19628=null;
var title_f19_10_19629="Congen melanocytic nevi FAQ";
var content_f19_10_19629=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PEDS%2F66620&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PEDS%2F66620&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Frequently asked questions regarding congenital melanocytic nevi",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1\">",
"        &nbsp;",
"       </td>",
"       <td class=\"subtitle1\">",
"        Small- and medium-sized CMN",
"       </td>",
"       <td class=\"subtitle1\">",
"        Large CMN",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        1. What is the lifetime risk for developing melanoma?",
"       </td>",
"       <td>",
"        Most likely &lt;1 percent",
"       </td>",
"       <td>",
"        Approximately 5 percent (highest risk if CMN has final size &gt;40 cm and truncal location)",
"       </td>",
"      </tr>",
"      <tr class=\"divider_top\">",
"       <td>",
"        2. Where do melanomas develop?",
"       </td>",
"       <td>",
"        Within the CMN; in the CNS if multiple CMN (&ge;3; usually numerous) and NCM",
"       </td>",
"       <td>",
"        Within the CMN; CNS (especially if risk factors for NCM &ndash; see below); other (eg, retroperitoneum)",
"       </td>",
"      </tr>",
"      <tr class=\"divider_top\">",
"       <td>",
"        3. If melanoma develops within the CMN, where does it start?",
"       </td>",
"       <td>",
"        Dermal-epidermal junction &gt;dermis",
"       </td>",
"       <td>",
"        Dermis/subcutis &gt;dermal-epidermal junction",
"       </td>",
"      </tr>",
"      <tr class=\"divider_top\">",
"       <td>",
"        4. When do most melanomas develop?",
"       </td>",
"       <td>",
"        At or after puberty",
"       </td>",
"       <td>",
"        Approximately 50 percent prior to age 5 years; remainder thereafter",
"       </td>",
"      </tr>",
"      <tr class=\"divider_top\">",
"       <td>",
"        5. Who is at increased risk for NCM?",
"       </td>",
"       <td>",
"        Individuals with multiple CMN (&ge;3; usually numerous)",
"       </td>",
"       <td>",
"        Those with multiple satellite nevi and/or a CMN with final size &gt;40 cm, usually with a posterior axial location",
"       </td>",
"      </tr>",
"      <tr class=\"divider_top\">",
"       <td rowspan=\"6\">",
"        6. What factors play a role in observation versus excision?",
"       </td>",
"       <td>",
"        &bull; Cosmetic concerns or functional issues",
"       </td>",
"       <td rowspan=\"6\">",
"        Location, size, and involvement of deeper structures (eg, fascia, muscle) can make complete excision technically difficult or impossible; aggressive surgery to remove the CMN should be postponed in patients with symptomatic NCM",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        &bull; Anxiety",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        &bull; Awareness/medical sophistication",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        &bull; Natural history of lesion",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1_start\">",
"        &bull; Factors that affect ease of monitoring:",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        <p>",
"         - Location (arm versus buttock)",
"        </p>",
"        <p>",
"         - Degree of pigmentation (tan versus black)",
"        </p>",
"        <p>",
"         - Thickness and topography (thin and uniform versus thick and multinodular)",
"        </p>",
"        <p>",
"         - Degree of hypertrichosis (minimal versus very dense)",
"        </p>",
"       </td>",
"      </tr>",
"      <tr class=\"divider_top\">",
"       <td>",
"        7. What methods are typically utilized for excision?",
"       </td>",
"       <td>",
"        Simple or staged excision; the latter can substantially reduce the size of the scar, especially for medium-sized CMN",
"       </td>",
"       <td>",
"        Staged excision with use of tissue expanders or (occasionally) skin grafting",
"       </td>",
"      </tr>",
"      <tr class=\"divider_top\">",
"       <td>",
"        8. What other treatment options are available for cosmetic improvement?",
"       </td>",
"       <td>",
"        Curettage (only during the neonatal period), lasers (eg, pigment-directed, ablative), dermabrasion; these procedures do not remove deep melanocytes",
"       </td>",
"       <td>",
"        Curettage (only during the neonatal period), lasers (eg, pigment-directed, ablative), dermabrasion; these procedures do not remove deep melanocytes",
"       </td>",
"      </tr>",
"      <tr class=\"divider_top\">",
"       <td>",
"        9. What techniques can be used to monitor CMN clinically?",
"       </td>",
"       <td>",
"        Visual inspection and palpation; dermoscopy; baseline photographs",
"       </td>",
"       <td>",
"        Visual inspection and palpation (eg, to detect indurated areas that may signify proliferation of deeper melanocytes); dermoscopy; baseline photographs",
"       </td>",
"      </tr>",
"      <tr class=\"divider_top\">",
"       <td>",
"        10. What complications other than melanoma and NCM can develop?",
"       </td>",
"       <td>",
"        Cosmetic and psychosocial issues",
"       </td>",
"       <td>",
"        Cosmetic and psychosocial issues; bulkiness (often due to neurotization); induration; pruritus; skin fragility; other malignancies (eg, rhabdomyosarcoma)",
"       </td>",
"      </tr>",
"      <tr class=\"divider_top\">",
"       <td>",
"        11. What imaging and consultations should be considered?",
"       </td>",
"       <td>",
"        MRI of brain &plusmn; spine for patients at risk for NCM (see above); dermatologist if concerning changes arise or excision is considered",
"       </td>",
"       <td>",
"        MRI of brain &plusmn; spine (the latter especially if CMN overlies posterior axis) for patients at risk for NCM (see above); dermatologist; neurologist for those with signs/symptoms of NCM; plastic surgeon; psychologist",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"     CMN: congenital melanocytic nevus; NCM: neurocutaneous melanosis.",
"    </div>",
"    <div class=\"reference\">",
"     Adapted with permission from: Marghoob AA. Congenital melanocytic nevi. Evaluation and management. Dermatol Clin 2002; 20:607. Copyright &copy; 2002 Elsevier.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f19_10_19629=[""].join("\n");
var outline_f19_10_19629=null;
var title_f19_10_19630="Contents: Immunizations and travel";
var content_f19_10_19630=[" <script type=\"text/javascript\">",
"  $$.inlineInitCustomer(",
"	false);",
"	var quirksmode = document.compatMode == \"CSS1Compat\";",
"	if (quirksmode) {",
"		$(\"html\").addClass(\"ie-standards\");",
"	}",
" </script>",
" <div id=\"message-wrap\">",
"  <div id=\"message-bg\">",
"  </div>",
"  <iframe id=\"message-bk\">",
"  </iframe>",
"  <dl id=\"message-container\">",
"   <dt id=\"message-title\">",
"   </dt>",
"   <dd id=\"message-body\">",
"   </dd>",
"   <dd id=\"message-controls\">",
"   </dd>",
"  </dl>",
" </div>",
" <div id=\"topPanel\">",
"  <div id=\"header\">",
"   <div id=\"header_container\">",
"    <h2 id=\"logo\">",
"     <a href=\"./toc\">",
"      Wolters Kluwer Health UpToDate",
"     </a>",
"    </h2>",
"    <div id=\"header_right\">",
"     <div id=\"searchpanel\">",
"      <a href=\"/login\" id=\"loginbutton\">",
"       Log in",
"      </a>",
"      <div id=\"cmsSearchBox\">",
"       <div class=\"header-search\">",
"        <form action=\"./search\" id=\"cmssearch\" method=\"get\" name=\"SearchForm\">",
"         <div class=\"header-search-left\">",
"          <input autocomplete=\"off\" class=\"searchfield\" id=\"cmsTxtBox\" name=\"search\" placeholder=\"Search UpToDate\" type=\"text\"/>",
"         </div>",
"         <div class=\"header-search-right\">",
"          <input alt=\"Search\" id=\"cmsSearchSubmit\" src=\"/sites/all/themes/uptodate/images/search_button.png\" type=\"image\"/>",
"         </div>",
"         <div class=\"clear\">",
"         </div>",
"        </form>",
"       </div>",
"      </div>",
"      <div id=\"cms_lang_dropdown\">",
"       <form accept-charset=\"UTF-8\" action=\"/\" id=\"lang-dropdown-form\" method=\"post\">",
"        <div class=\"form-item form-type-select form-item-lang-dropdown-select\">",
"         <select class=\"lang-dropdown-select-element form-select\" id=\"edit-lang-dropdown-select\" name=\"lang_dropdown_select\" style=\"width:100px\">",
"          <option selected=\"selected\" value=\"en\">",
"           English",
"          </option>",
"          <option value=\"ja\">",
"           ",
"          </option>",
"         </select>",
"        </div>",
"        <input name=\"lang_dropdown_type\" type=\"hidden\" value=\"language\">",
"         <input name=\"en\" type=\"hidden\" value=\"/\">",
"          <input name=\"ja\" type=\"hidden\" value=\"/ja\">",
"           <noscript>",
"            <div>",
"             <input class=\"form-submit\" id=\"edit-submit\" name=\"op\" type=\"submit\" value=\"Go\"/>",
"            </div>",
"           </noscript>",
"           <input name=\"form_build_id\" type=\"hidden\" value=\"form-on4lUWpxHun_wp6revUkjCG6rK2IBuCGME9Cw0HXeok\">",
"            <input name=\"form_id\" type=\"hidden\" value=\"lang_dropdown_form\">",
"            </input>",
"           </input>",
"          </input>",
"         </input>",
"        </input>",
"       </form>",
"      </div>",
"      <div class=\"clear\">",
"      </div>",
"     </div>",
"     <ul id=\"utility\">",
"      <li class=\"first\">",
"       <a href=\"/home/about-us\">",
"        About Us",
"       </a>",
"      </li>",
"      <li>",
"       <a href=\"/home/news-events\">",
"        News &amp; Events",
"       </a>",
"      </li>",
"      <li>",
"       <a href=\"/home/contact-us\">",
"        Contact Us",
"       </a>",
"      </li>",
"      <li class=\"last\">",
"       <a href=\"/help\">",
"        Help",
"       </a>",
"      </li>",
"     </ul>",
"    </div>",
"    <div class=\"clear\">",
"    </div>",
"   </div>",
"   <div id=\"nav\">",
"    <ul>",
"     <li id=\"productTab\">",
"      <a href=\"/home/product\">",
"       Product",
"       <span>",
"       </span>",
"      </a>",
"     </li>",
"     <li id=\"editoralTab\">",
"      <a href=\"/home/editorial\">",
"       Editorial",
"       <span>",
"       </span>",
"      </a>",
"     </li>",
"     <li id=\"whyUptodateTab\">",
"      <a href=\"/home/why-uptodate\">",
"       Why UpToDate",
"       <span>",
"       </span>",
"      </a>",
"     </li>",
"     <li id=\"supscriptionOptionsTab\">",
"      <a href=\"/home/subscription-options\">",
"       Subscription Options",
"       <span>",
"       </span>",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"/store\">",
"       Subscribe",
"       <span>",
"       </span>",
"      </a>",
"     </li>",
"     <li id=\"wkhcsTab\">",
"      <a href=\"/home/wolters-kluwer-health-clinical-solutions\">",
"       Wolters Kluwer Health Clinical Solutions",
"       <span>",
"       </span>",
"      </a>",
"     </li>",
"    </ul>",
"    <div class=\"clear\">",
"    </div>",
"   </div>",
"   <div id=\"greyBar\">",
"    <div id=\"greyBarTitle\">",
"     <span class=\"emphasis\">",
"      <a href=\"UTD.htm?3/3/3134\">",
"       Contents",
"      </a>",
"     </span>",
"     <img src=\"./../images/space_arrows.myextg\">",
"      <a href=\"UTD.htm?15/21/15710\">",
"       Infectious Diseases",
"      </a>",
"      <img src=\"./../images/space_arrows.myextg\">",
"       Immunizations and travel",
"      </img>",
"     </img>",
"    </div>",
"    <div id=\"greyBarButtons\">",
"     <div id=\"printGB\">",
"      <a class=\"icontxt\" href=\"?view=print\">",
"       <img align=\"middle\" alt=\"Print this page\" border=\"0\" height=\"20\" src=\"./../images/icn_print.myextg\" width=\"24\"/>",
"      </a>",
"      <a class=\"icontxt\" href=\"?view=print\" title=\"Print this page\">",
"       Print",
"      </a>",
"     </div>",
"    </div>",
"   </div>",
"   <!-- menuMessage.jsp -->",
"   <!-- /menuMessage.jsp -->",
"  </div>",
"  <!-- header -->",
" </div>",
" <!-- topPanel -->",
" <div id=\"leftPanel\">",
"  <ul>",
"   <li>",
"    <a href=\"UTD.htm?3/45/3806\">",
"     Specialties",
"    </a>",
"   </li>",
"   <li>",
"    <a href=\"UTD.htm?18/22/18798\">",
"     Patient Information",
"    </a>",
"   </li>",
"   <li>",
"    <a href=\"UTD.htm?3/13/3294\">",
"     What's New",
"    </a>",
"   </li>",
"   <li>",
"    <a href=\"UTD.htm?0/37/606\">",
"     Calculators",
"    </a>",
"   </li>",
"   <li>",
"    <a href=\"UTD.htm?0/40/654\">",
"     Authors and Editors",
"    </a>",
"   </li>",
"  </ul>",
" </div>",
" <!-- leftPanel -->",
" <div id=\"rightPanel\">",
"  <noscript>",
"   <div id=\"javascriptDisabled\">",
"    It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"   </div>",
"  </noscript>",
"  <div id=\"printHeader\">",
"   <div id=\"printHeaderLogo\">",
"    <img alt=\"UpToDate\" src=\"./../images/wk_utd-rgb.myextg\" width=\"220px\">",
"    </img>",
"   </div>",
"   <div id=\"printHeaderText\">",
"    Official reprint from UpToDate",
"    <sup>",
"     &reg;",
"    </sup>",
"    <a href=\"file://www.uptodate.com\">",
"     www.uptodate.com",
"    </a>",
"    <br>",
"     &copy;2013 UpToDate",
"     <sup>",
"      &reg;",
"     </sup>",
"    </br>",
"   </div>",
"   <div id=\"printHeaderLinks\">",
"    <a href=\"#\" id=\"printHeaderPrint\" rel=\"\" title=\"Click here to print\">",
"     Print",
"    </a>",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"     Back",
"    </a>",
"   </div>",
"  </div>",
"  <div class=\"toctable\" border=\"0\" cellpadding=\"0\" cellspacing=\"0\" id=\"tocTable\" width=\"100%\">",
"   <trs>",
"    <tds>",
"     <h1>",
"      Contents:",
"			Immunizations and travel",
"     </h1>",
"    </tds>",
"   </trs>",
"   <trs>",
"    <tds>",
"    </tds>",
"   </trs>",
"   <trs>",
"    <tds valign=\"top\">",
"     <div class=\"toctable\" border=\"0\" cellpadding=\"0\" cellspacing=\"0\" width=\"100%\">",
"      <trs>",
"       <tds>",
"        <strong>",
"         Immunizations",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?40/44/41670\">",
"           Approach to immunizations in healthy adults",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?1/38/1641\">",
"           Hepatitis A virus vaccination and postexposure prophylaxis",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?30/60/31690\">",
"           Hepatitis B virus vaccination",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?24/57/25498\">",
"           Immunizations after hematopoietic cell transplantation",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?31/53/32602\">",
"           Immunizations during pregnancy",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?13/0/13322\">",
"           Immunizations for healthcare providers",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?8/23/8569\">",
"           Immunizations for patients with chronic liver disease",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?2/21/2394\">",
"           Immunizations for travel",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?36/25/37273\">",
"           Immunizations in HIV-infected patients",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?29/37/30296\">",
"           Immunizations in patients with cancer",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?22/48/23306\">",
"           Immunizations in solid organ transplant candidates and recipients",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?14/30/14822\">",
"           Measles-mumps-rubella vaccination in high risk adults",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?22/32/23050\">",
"           Meningococcal vaccines",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?10/50/11047\">",
"           Pneumococcal immunization in HIV-infected patients",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?21/12/21705\">",
"           Pneumococcal vaccination in adults",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?16/52/17223\">",
"           Poliovirus vaccination",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?22/16/22793\">",
"           Prevention and treatment of measles",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?2/21/2393\">",
"           Rabies immune globulin and vaccine",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?36/8/37002\">",
"           Seasonal influenza vaccination in adults",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?6/54/7014\">",
"           Tetanus-diphtheria toxoid vaccination in adults",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?40/1/40984\">",
"           Vaccines for the prevention of group B streptococcal disease",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?39/7/40057\">",
"           Vaccinia virus as the smallpox vaccine",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?19/39/20088\">",
"           When to use rabies prophylaxis",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Snake bite",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?5/52/5962\">",
"           Management of Crotalinae (rattlesnake, water moccasin [cottonmouth], or copperhead) bites in the United States",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?30/44/31431\">",
"           Principles of snake bite management worldwide",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Travel issues",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?3/5/3161\">",
"           Diseases potentially acquired by travel to Central and South America",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?13/0/13319\">",
"           Diseases potentially acquired by travel to East Asia",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?12/17/12568\">",
"           Diseases potentially acquired by travel to Southeast Asia",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?39/11/40121\">",
"           Diseases potentially acquired by travel to sub-Saharan Africa",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?38/24/39304\">",
"           Evaluation of fever in the returning traveler",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?8/57/9113\">",
"           Potential health hazards in travelers to Australia, New Zealand, and the southwestern Pacific (Oceania)",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?13/3/13370\">",
"           Prevention of malaria infection in travelers",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?19/43/20152\">",
"           Skin lesions in the returning traveler",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?8/48/8967\">",
"           Travel advice",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?12/49/13081\">",
"           Travel advice for immunocompromised hosts",
"          </a>",
"         </li>",
"        </ul>",
"       </tds>",
"      </trs>",
"     </div>",
"    </tds>",
"   </trs>",
"   <trs>",
"    <tds>",
"     <img height=\"10\" src=\"./../images/spacer.myextg\" width=\"1\"/>",
"    </tds>",
"   </trs>",
"  </div>",
"  <div id=\"footer\">",
"   <div id=\"footerNav\">",
"    <ul>",
"     <li>",
"      <a href=\"file://www.wolterskluwerhealth.com/\" rel=\"nofollow\" target=\"_blank\">",
"       Wolters Kluwer Health",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://www.factsandcomparisons.com/\" rel=\"nofollow\" target=\"_blank\">",
"       Facts &amp; Comparisons&reg;",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://www.medispan.com\" rel=\"nofollow\" target=\"_blank\">",
"       Medi-Span&reg;",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://www.provationordersets.com\" rel=\"nofollow\" target=\"_blank\">",
"       ProVation&reg; Order Sets",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://www.provationmedical.com\" rel=\"nofollow\" target=\"_blank\">",
"       ProVation&reg; Medical",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://pharmacyonesource.com/\" rel=\"nofollow\" target=\"_blank\">",
"       Pharmacy OneSource&reg;",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://www.medicom.com.cn/\" rel=\"nofollow\" target=\"_blank\">",
"       Medicom",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://www.lexi.com/\" rel=\"nofollow\" target=\"_blank\">",
"       Lexicomp",
"      </a>",
"     </li>",
"     <li class=\"last\">",
"      <a href=\"/home/privacy-policy\">",
"       Privacy Policy",
"      </a>",
"     </li>",
"    </ul>",
"   </div>",
"   <div id=\"footerLogo\">",
"    <a href=\"./toc\">",
"     Wolters Kluwer Health | UpToDate",
"    </a>",
"   </div>",
"   <div id=\"supportFooter\">",
"    <span class=\"sfInfo\">",
"     &copy; 2013 UpToDate, Inc. All rights reserved.",
"    </span>",
"    <span class=\"sfInfo\">",
"     <span class=\"pipeSpace\">",
"      |",
"     </span>",
"     Release: 21.3 - C21.34",
"    </span>",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    <span class=\"sfInfo\">",
"     <a href=\"/home/terms-use\">",
"      Terms of Use",
"     </a>",
"    </span>",
"    <br/>",
"    <span class=\"sfInfo\">",
"     Licensed to:",
"     <span class=\"emphasis\">",
"      UpToDate Marketing Professional",
"     </span>",
"    </span>",
"    <span class=\"sfInfo\">",
"     <span class=\"pipeSpace\">",
"      |",
"     </span>",
"     Support Tag: [0605-95.154.198.148-CC5687189B-14]",
"     <br/>",
"    </span>",
"   </div>",
"  </div>",
" </div>",
" <!-- rightPanel -->",
"</body>"].join("\n");
var script_f19_10_19630=[""].join("\n");
var outline_f19_10_19630=null;
var title_f19_10_19631="Mechanical triggering PI";
var content_f19_10_19631=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PI%2F80186&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PI%2F80186&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Trigger finger",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 369px; height: 275px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    When a person with trigger finger straightens the fingers, the condition causes a finger to \"catch\" or \"lock\" in the bent position.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Bruce C Anderson, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f19_10_19631=[""].join("\n");
var outline_f19_10_19631=null;
